|
In Play®
|
||
| 16:10 | TWP Trex Company announces refinancing of revolving credit facility (17.25 +0.14) | |
| Co announced that it has successfully refinanced its revolving credit facility. The new $85 mln facility matures on December 31, 2011 and can be extended to December 31, 2012 if certain conditions are met. There has been no borrowing on the new line. As part of the refinancing process, the company paid off its existing real estate loans with BB&T Company in the amount of ~$5 mln with available cash. | ||
| 16:07 | Conferences and Shareholder/Analyst Meetings of Interest | |
| Some notable events scheduled for the week of Nov 9 -- Nov 13 are listed below. For a complete list of next week's events, please see the events calendar. Monday: - CSCO Collaboration Summit 2009 - HXL, NCIT at Stifel, Nicolaus & Company Aerospace/Defense/Airline Conference - 3-month and 6-month Treasury Bill Auctions Tuesday: - BAC, GS, MS, TD at Bank of America Merrill Lynch Banking and Financial Services Conference - ADBE, NFLX, YHOO, RHT at Piper Jaffray Global Internet Summit - $25 bln 10-yr Treasury Note Auction Wednesday: - K Analyst Day - AMD Analyst Day - GR, TNB, NSC, UNP at Citi Industrial Manufacturing & Transportation Conference Thursday: - CSX, DHR, GE, CAT at Citi Industrial Manufacturing & Transportation Conference - BPI, COCO, LRN, CPLA at Signal Hill Education Preview Investor Conference - $16 bln 30-yr Treasury Bond Auction Friday: - WMGI, DNDN, POZN, LLY Credit Suisse Healthcare Conference - Fed's Evans; France's Governor Noyer |
||
|
||
| 15:41 | Earnings Preview for the week of Nov 9th-13th | |
| Of the hundreds of companies reporting earnings the week Nov 9th-13th some of the bigger names include: Monday: GIB, CFSG, DISH, SATS, FUQI, NOOF, SEPR, DIVX, FLR, SOLR, FRPT, LGF, and SQNM... Tuesday: BZH, DSX, JASO, TYC, HOGS, AONE, STV, CLWR, and WTW... Wednesday: CAE, M, AMAT, CTFO, CTRP, DNDN, GMCR, and TTEK... Thursday: BPHX, BRKS, ECA, GSOL, KSS, URBN, WMT, BBI, CPA, DAR, MDSO, JWN, and DIS... Friday: ANF, A, JCP, TK, and YGE. | ||
| 15:09 | GBL GAMCO Investors Board declares special cash dividend of $2.00 per share and Q4 dividend of $0.03 per share (46.00 +0.56) | |
| 14:52 | COMDX CBOT Agriculture and Ethanol and ICE Exchange Sugar Closing Prices | |
| December corn closed lower by 9.25 cents to $3.6725 per bushel, January soybeans closed lower by 14.5 cents to $9.575 per bushel, December wheat closed lower by 14.75 cents at $4.975 per bushel, December Ethanol closed lower by $0.015 to $1.85 per gallon, March world sugar futures closed lower by 0.33 cents at 22.43 cents per pound. | ||
| 14:31 | SBUX Starbucks breaks to fresh gap up highs as it elevates modestly above its Sep-Oct range/52-wk high of 21.11 (21.19 +1.49) -Update- -Technical- | |
| 14:01 | ROP Roper Inds announces two acquisitions to enhance growth in medical and toll & traffic businesses (5176 -0.37) | |
| Co announces it has signed a definitive agreement to acquire Verathon, a provider of proprietary medical devices. Roper also announced it has acquired the assets of United Toll Services. Headquartered in Montgomery, Alabama, UTS provides software and in-lane hardware systems for toll and traffic solutions. The total investment for these transactions will be approximately $356 million. The company expects these two transactions will add more than $140 million to 2010 revenue with at least $38 million of EBITDA. | ||
| 13:32 | COMDX COMEX Metals Closing Prices | |
| Gold finished the session higher by $6.70 to $1096.00, silver shed 3.5 cents to end at $17.375, and copper closed off 0.3 cents to $2.954 (all Dec contracts). | ||
| 13:30 | AMAT Applied Materials acquires the assets of Advent Solar (12.41 +0.01) | |
| Co announces it has acquired substantially all the assets, including the intellectual property, of Advent Solar for an undisclosed cash amount. Advent Solar is a developer of advanced technology for crystalline silicon (c-Si) PVs. This acquisition is expected to complement Applied's portfolio of solar PV technologies and enhance its leadership in the c-Si equipment market. | ||
| 12:46 | Rumor Roundup | |
| With regard to market rumors, today closes out the week on a quiet note. To recap this morning's chatter, we note that a rumor circulated suggesting Proctor & Gamble (PG) could be interested in Clorox (CLX). We'd note that yesterday it was rumored that PG was interested in NWL. It was also rumored that Google (GOOG) could be interested in Akamai (AKAM), we note the stock has not reacted positively to the renewed speculation, but options volume is elevated in AKAM. As mentioned before, while many rumors circulate during the day, and the validity of the source of these rumors can be questionable, the speculation may increase volatility in the near term. | ||
| 12:09 | CBRL Cracker Barrel announces amendment of credit agreement (33.57 -0.25) | |
| Co announced that it has entered into an amendment to its existing credit facilities. The amendment extends the availability of $165 million of the $250 million currently available under the Company's revolving credit facility to January 2013 from April 2011. The maturity of $250 million of its existing $643 million term loans was extended by three years to April 2016. The current interest rates on the term loans are Libor + 150 bps on the non-extended portion and Libor + 250 bps on the extended portion. | ||
| 12:04 | AEE Ameren reduces staff by 300 positions (24.77 +0.02) | |
| 11:36 | CAL Airlines starting to display some relative strength here as crude continues to head lower -- CAL, UAUA, ALK, AMR, CPA. JBLU, LUV, SKYW -Technical- | |
| 11:32 | WRES Warren Resources announces new hedges and updates hedge position (2.30 -0.03) | |
| The co announces that it has expanded its commodity hedge program by entering into a zero cost collar on 1,000 barrels of crude oil per day for all of 2010. Under the terms of this transaction, the Company places a floor of $65.00 per barrel and a ceiling of $106.50 per barrel. The costless collar is used to establish a floor price by purchasing a put and a ceiling price by selling a call on anticipated future crude oil production. | ||
| 11:30 | FDX FedEx pushes higher intraday as it elevates up into fresh 8-day high territory back above the 76.00 area (76.31 +1.31) -Technical- | |
| 11:16 | SBUX Starbucks hovering near session high at 20.80 (20.78 +1.08) -Update- -Technical- | |
| Highlighted the test of its week long range top at 19.71 yesterday with today's extension of the breakout on earnings leaving the stock slightly under its 52-wk close high from Oct at 20.94 (also Sep high). The 52-wk intraday high from Oct comes into play thereafter at 21.11. | ||
| 11:06 | NVDA NVIDIA extends its gap up open higher intraday as it comes into its 50-day ema at 13.40 (13.31 +1.05) -Update- -Technical- | |
| 10:36 | COMDX Crude oil puts in fresh lows at $77.10; now down $2.40 to $77.22 | |
| 10:33 | ELMG EMS Tech announces it is initiating share repurchases under its previously announced authorization to purchase shares costing up to an aggregate of $20 mln (19.41 -0.05) | |
| 10:32 | COMDX Crude oil retraces its bounce and is looking to test session lows at $77.30; now down $2.09 to $77.53 | |
| 10:27 | USO U.S. Oil Fund ETF gives up its initial gap down lift as it sinks to fresh lows near its 20-day ema at 39.70 (39.66 -1.16) -Technical- | |
| Would note that the recent reaction low is below at 39.20. | ||
| 10:02 | ACGL Arch Capital announces additional $1 bln share repurchase authorization (68.71 +0.77) | |
| Co announces that its Board of Directors authorized the Company to invest up to an additional $1 bln in the Co's common shares. This authorization is in addition to the $350.1 mln available at September 30, 2009 under the Board's previous share repurchase authorizations. Repurchases under the new authorization may be effected from time to time in open market or privately negotiated transactions through December 31, 2011. | ||
| 10:01 | CSTR Coinstar continues its early morning gap down aggressive sell off as it nears a test of the 26.00 support area below (26.71 -5.22) -Update- -Technical- | |
| 10:01 | TACT Transact Tech announces its Epic 950 printer was selected exclusively by Spielo Manufacturing (6.68 -0.10) | |
| Co announces its Epic 950 printer was selected exclusively by Spielo Manufacturing, a wholly-owned subsidiary of Lottomatica Group S. p. A., to be installed in all of its new Comma 6b server-based video lottery terminals in Italy. Approximately $1 million of printers will ship in 2009 -- most in the fourth quarter of 2009 -- and a projected additional $2 million are expected to ship throughout 2010, with the printers being installed inside SPIELO's VLTs to be shipped to Lottomatica and other Italian VLT concessionaires. | ||
| 09:55 | CPD Caraco Pharma markets generic Acular Opthalmic Solution (4.00 +0.15) | |
| Co announces it has launched ketorolac tromethamine ophthalmic solution, 0.5% following a final approval from the FDA for Sun Pharma's Abbreviated New Drug Application for generic Acular opthalmic solution on the first day following patent expiration. | ||
| 09:50 | ECONX Reminder: Wholesale Inventories data due out in about 10 min at 10:00ET | |
| 09:44 | COMDX Gold breaks through the $1100 level to put in new all time highs at $1101, as the dollar pulls back; now higher by $11.00 to $1100.30 | |
| 09:41 | GDX Mkt Vctrs Gold Miners displays relative strength off the open as they stage a strong opening rise higher -- AEM, GG, GFI, RGLD, GOLD, AUY, KGC, NEM, ABX (47.73 +1.02) -Technical- | |
| 09:10 | AUO AU Optronics reports Oct. 2009 consolidated revs of NT$39.6 bln, up 45.3% y/y (9.31 ) | |
| 09:02 | AER AerCap beats by $0.02, misses on revs (8.90 ) | |
| Reports Q3 (Sep) earnings of $0.42 per share, $0.02 better than the First Call consensus of $0.40; revenues fell 29.6% year/year to $212.5 mln vs the $274.8 mln consensus. The decrease was mainly due to lower aircraft sales revenue and lower maintenance revenue, partially offset by higher basic lease revenue. | ||
| 09:01 | ONCY Oncolytics Biotech collaborators present "positive Phase II Sarcoma trial results" at CTOS Annual Meeting (3.30 ) | |
| Co announces updated results from a Phase II study of intravenous REOLYSIN in patients with sarcomas metastatic to the lung in a poster presentation at the 15th Annual Connective Tissue Oncology Society Meeting. The investigators reported that the treatment has been well tolerated to date, and that 19 of 44 evaluable patients experienced stable disease ranging from two to 20 months, resulting in a total clinical benefit rate (complete response + partial response + stable disease) of 43%. The response objective for the study was three or more patients having prolonged stabilization of disease (greater than 6 months) or better, for the agent to be considered. The trial exceeded its established objective with six patients experiencing stable disease for more than six months. Two patients have experienced stable disease for more than 19 months. One has synovial cell sarcoma that relapsed following surgery, while the other has Ewing's Sarcoma and had previously progressed following multiple treatments. "We were very happy to participate in the study," said Dr. Mita. "REOLYSIN is a promising option for patients with sarcoma as shown by the results of this study. As a single agent the virus had a clinical benefit rate of 43% and it was very well tolerated. Further studies combining REOLYSIN with chemotherapy are contemplated in order to integrate the virus in the panoply of agents used for sarcoma treatment." | ||
| 09:00 | EBAY eBay and Silver Lake Investor Group settle Skype litigation with Joltid (23.24 ) | |
| EBAY announces that the investor group led by Silver Lake, which had previously entered into a definitive agreement to acquire a majority stake in Skype from the company, has reached a settlement agreement with Joltid Limited and Joost that gives Skype ownership over all software previously licensed from Joltid and ends all litigation currently pending against the investor group and eBay at the closing of the acquisition. As part of the settlement agreement, Joltid and Skype founders Niklas Zennstrom and Janus Friis will join the investor group, contributing Joltid software and making a significant capital investment in exchange for a 14% stake in Skype. As a result, Silver Lake and other investors including Andreessen Horowitz and the Canada Pension Plan Investment Board, will together hold 56% of Skype and eBay will retain 30%. As previously announced, eBay will receive approximately $1.9 bln in cash upon the completion of the sale and a note from the buyer in the principal amount of $125 mln. The deal, which values Skype at $2.75 bln and is not subject to a financing condition, is expected to close in the fourth quarter of 2009. | ||
| 08:51 | COMDX Gold and silver quickly reverse their respective moves to the upside to give back overnight gains; gold now off $1.20 to $1088 and silver is lower by 7 cents to $17.34 | |
| Crude oil has also dropped to its lowest levels and is now lower by $2.20 to $77.42. | ||
| 08:47 | MKM Partners Car Rental cos; initiates CAR and DTG with a Buy and HTZ with a Neutral | |
| MKM Partners initiates CAR and DTG with a Buy and establishes tgts of $18 and $33, respectively. In addition, the firm initiates HTZ with a Neutral and sets a $13 tgt. For CAR, the firm believes the co is at the start of a three stage earnings recovery as the current strong leisure pricing environment continues into 2010, corporate travel volumes first stabilize and then recover due to GDP growth and easier year/year comps. Meanwhile for DTG, the firm believes that current strong leisure pricing can continue into 2010 due to tight-industry fleeting and stabilizing demand. The firm notes that DTG is a leisure travel pure-play and the most levered to stronger leisure pricing. The firm notes that structural changes in the industry, such as consolidation and independence from the US auto OEMs, as well as increased financing and collateral requirements, in the firm's view, will combine to restrict vehicle inventories. However, this should drive stronger pricing for leisure rentals which react more quickly to changes in demand/supply. Finally for HTZ, the firm believes the co 's diverse revenue streams capture current strong leisure pricing, position the company for a rebound in corporate travel and enable Hertz to benefit from international growth opportunities and a weaker U.S. dollar. | ||
| 08:47 | THLD Threshold Pharma presents interim data from a Phase 1/2 clinical trial of TH-302; twelve patients have had at least one evaluable post-treatment tumor assessment (2.66 ) | |
| Co announces clinical trial results related to it's clinical stage hypoxia-activated prodrug, TH-302. Today's presentation focused on a clinical trial, the 403 trial, which is investigating TH-302 in combination with doxorubicin in patients with soft tissue sarcoma who have not received prior doxorubicin. Twelve patients have had at least one evaluable post-treatment tumor assessment, including 3 (25%) with a partial response as measured by RECIST. Two of the P.R.s are confirmed, including one patient who has remained on study for 33 weeks. One of the PRs was unconfirmed due to progression at the subsequent assessment. Five of the 12 patients continue to receive TH-302 after receiving TH-302 for 3 to 13 three-week cycles. Seven (58%) patients achieved stable disease while 2 (17%) had progressive disease. Additional patients are being enrolled to better define the extent of the tumor response activity. TH-302 continues to be tolerated and there have been no new unexpected adverse events in the 14 patients assessed for safety. | ||
| 08:41 | COMDX Crude oil is trading at its worst levels of the morning, following the release of the jobs data; at $78.35; now off $1.20 to $78.42 | |
| Despite the fact that the dollar is moving higher following this econ data, gold has spiked to a new all time high at $1098.60; currently higher by $8.80 to $1098.20. | ||
| 08:38 | BSX Boston Scientific announces agreement with DOJ on pre-acquisition investigation of Guidant; reaffirms FY09 EPS of $0.75-$0.79 vs $0.51 consensus (8.05 ) | |
| Co announces that it has reached an agreement in principle with the U.S. Department of Justice related to product advisories issued by its Guidant subsidiary in 2005. The alleged conduct and product sales occurred prior to Boston Scientific's 2006 acquisition of Guidant. Boston Scientific had previously disclosed an investigation by the U.S. Attorney's Office in Minneapolis into alleged violations of the Food, Drug, and Cosmetic Act by Guidant. Under the terms of the agreement, Guidant will plead to two misdemeanor charges related to failure to include information in reports to the FDA, and Boston Scientific will pay $296 million on behalf of Guidant... Accordingly, the co has updated its financial results for the third quarter and nine months ended Sept 30, 2009, recording a third quarter charge of $294 mln, on both a pre-tax and after-tax basis. This amount represents the $296 mln charge associated with the agreement net of a $2 million reversal of a related accrual... The Company continues to expect FY09 adjusted earnings of $0.75-$0.79 vs $0.51 consensus | ||
| 08:37 | BX Blackstone beats by $0.10, beats on revs (13.87 ) | |
| Reports Q3 (Sep) earnings of $0.25 per share, $0.10 better than the First Call consensus of $0.15. BX reports revenues of $603 mln compared to First Call consensus of $450 mln; The fair value of the Real Estate portfolio depreciated by 0.4% in the third quarter of 2009, versus 10% in the third quarter of 2008. The Blackstone Group L.P. has declared a quarterly distribution of $0.30 per common unit to record holders of common units at the close of business on November 30, 2009. | ||
| 08:36 | BRNC Bronco Drilling misses by $0.04, misses on revs (6.15 ) | |
| Reports Q3 (Sep) loss of $0.37 per share, excluding non-recurring items, $0.04 worse than the First Call consensus of ($0.33); revenues fell 41.1% year/year to $16.2 mln vs the $18.2 mln consensus. | ||
| 08:34 | EIX Edison beats by $0.05, misses on revs; guides FY09 EPS in-line (32.18 ) | |
| Reports Q3 (Sep) earnings of $1.09 per share, $0.05 better than the First Call consensus of $1.04; revenues fell 14.7% year/year to $3.66 bln vs the $3.76 bln consensus. Co issues narrowed in-line guidance for FY09, sees EPS of $2.95-3.15 vs. $3.02 consensus, previous guidance was $2.90-3.20. The decline is largely attributable to lower earnings at Edison Mission Group (EMG), partially offset by higher operating results at Southern California Edison (SCE). | ||
| 08:34 | LMIA LMI Aerospace misses by $0.04, misses on revs (11.37 ) | |
| Reports Q3 (Sep) earnings of $0.25 per share, $0.04 worse than the First Call consensus of $0.29; revenues fell 5.2% year/year to $58.7 mln vs the $62.8 mln consensus. | ||
| 08:33 | NNN National Retail Properties reports EPS in-line, beats on revs; guides FY10 FFO below consensus (19.75 ) | |
| Reports Q3 (Sep) funds from operations of $0.39 per share, in-line with the First Call consensus of $0.39; revenues fell 2.5% year/year to $57 mln vs the $55.9 mln consensus. Co issues downside guidance for FY10, sees FFO of $1.51-1.58 vs. $1.65 consensus. | ||
| 08:32 | NUVA NuVasive appoints Michael J. Lambert as new Chief Financial Officer (37.39 ) | |
| Co announces the appointment of Michael J. Lambert as Executive Vice President and Chief Financial Officer, effective November 9, 2009. | ||
| 08:18 | ECONX Reminder: Jobs reports due out in about 12 min at 8:30ET | |
| 08:17 | RAIL Freightcar America misses by $0.13, misses on revs (25.60 ) | |
| Reports Q3 (Sep) earnings of $0.09 per share, $0.13 worse than the First Call consensus of $0.22; revenues fell 76.8% year/year to $55.1 mln vs the $78 mln consensus. There were no net orders for new railcars in the third quarter of 2009, compared to 694 units ordered in the second quarter of 2009, and 2,329 units ordered in the third quarter of 2008. Railcar deliveries totaled 695 units in the third quarter, compared to 1,207 units delivered in the second quarter of 2009 and 3,082 units delivered in the third quarter of 2008. Total backlog of unfilled orders was 777 units at the end of the third quarter, compared with 1,472 units at the end of the second quarter of 2009 and 4401 units at the end of the third quarter of 2008. "The decline in order activity in the quarter illustrates that the market for new railcars remains very challenging. However, I believe we are performing well in a difficult environment." | ||
| 08:17 | GOL GOL Linhas Areas Inteligentes announces preliminary traffic figures for October 2009 (11.40 ) | |
| Co announces demand growth in the domestic market of 46.9% over the same month last year, chiefly due to positioning in that market, with high-frequency flights between airports in densely populated cities and dynamic yield management, underpinned by high- quality service, punctuality and regularity. In addition, the month's figures were still reflecting the upturn in demand triggered by the exceptionally competitive scenario in September and the first ten days of October. Domestic demand climbed by 14.1% over September 2009, or 10.4% if the number of calendar days in each month are equalized. | ||
| 08:11 | On The Wires | |
| Halliburton (HAL) announces that it has been awarded the integrated turnkey drilling contract in South Ghawar. Located approximately 200 kilometers from the city of Dhahran, the Ghawar field is the world's largest oil field and the contract would involve work in Uthmaniyah, Haradh, Hawiyah and Shedgum. The five-year contract, with an option for an additional five-year period, calls for the provision of drilling rigs, directional and horizontal drilling, logging while drilling, cementing, mud engineering, wireline logging, completion, perforating, and other well construction activities, including engineering and management of the entire drilling operations... CSC (CSC) announces that it has signed a contract for a range of IT services for Raytheon Company (RTN). The contract has a five-year base period with two one-year options, and runs through February 2015. Additional terms of the contract were not disclosed... Charles & Colvard (CTHR) announces that it has signed a new and expanded distribution agreement with Stuller. Under the terms of the agreement, Stuller has the right to sell Charles & Colvard Created Moissanite as either a loose jewel or in manufactured jewelry in North America through December 31, 2010. | ||
| 08:06 | XOMA XOMA Limited expands development strategy for XOMA 052 to include cardiovascular diseases (0.74 ) | |
| Co announces the expansion of its development strategy for its XOMA 052 antibody to interleukin-1 beta to include effects on cholesterol lowering, reducing plaque deposits and damage to heart muscle and resulting long-term effects that can lead to heart attack, stroke and congestive heart failure. The strategy is supported by results from XOMA 052 Phase 1 trials demonstrating improvement in biomarkers associated with cardiovascular risk, ongoing clinical trials in cardiovascular disease with other IL-1 targeted agents, animal studies with XOMA 052 that have demonstrated significant reductions in plaque formation and improvements in lipid levels, and positive results with another IL-1 targeted agent in an animal model of cardiac remodeling after heart attack. XOMA's current XOMA 052 program is focused on Type 2 diabetes and this expansion represents an enormous increase in the number of patients who could be helped by this general anti-inflammatory approach. | ||
| 08:04 | SEP Spectra Energy LP beats by $0.05, beats on revs (26.25 ) | |
| Reports Q3 (Sep) earnings of $0.48 per share, $0.05 better than the First Call consensus of $0.43; revenues rose 68.8% year/year to $49.8 mln vs the $45.2 mln consensus. | ||
| 08:04 | LOGM LogMeIn files registration statement for proposed public offering of 3,000,000 shares of common stock (20.02 ) | |
| Co announces that it has filed a registration statement with the U.S. Securities and Exchange Commission for a proposed offering of 3,000,000 shares of common stock, of which up to 100,000 are expected to be offered by the Company and 2,900,000 are expected to be offered by selling stockholders. LogMeIn will not receive any proceeds from the expected sale of the shares offered by the selling stockholders. | ||
| 08:03 | NVAX Novavax reports Q3 loss per share of $0.08, beats consensus by $0.01 (4.03 ) | |
| Reports Q3 (Sep) loss of $0.08 per share, $0.01 better than the First Call consensus of ($0.09). Reports revenue of $201K vs $194K year ago. Co states, "We are continuing to make rapid progress with each of our vaccine development programs which are targeting some of the world's most pressing public health problems. Our partnerships in the United States, Spain, Mexico and India are accelerating the development of our VLP based 2009 H1N1 pandemic influenza and seasonal influenza vaccines and enabling us to prepare for their commercial-scale production. In addition, we recently selected a vaccine candidate against Respiratory Syncytial Virus, the most common cause of lower respiratory tract infection in infants and young adults. Our achievements to date reflect the clinical and commercial potential of our technology and the successful execution of our product development strategies." | ||
| 08:03 | KNOL Knology misses by $0.02, misses on revs (10.52 ) | |
| Reports Q3 (Sep) earnings of $0.05 per share, $0.02 worse than the First Call consensus of $0.07; revenues rose 2.5% year/year to $105.8 mln vs the $107.5 mln consensus. Subsequent to quarter end, Knology executed a definitive agreement to acquire the assets of Private Cable, a provider of video, voice and data services to residential and business customers in Athens and Decatur, Alabama for $7.5 million cash, to be funded from Knology's cash on hand. The transaction is expected to close during the fourth quarter of 2009. | ||
| 08:02 | PSMT PriceSmart beats by $0.05, reports revs in-line (19.98 ) | |
| Reports Q4 (Aug) earnings of $0.35 per share, $0.05 better than the First Call consensus of $0.30; revenues rose 4.5% year/year to $305.1 mln vs the $307.2 mln consensus. PriceSmart also announced that for the month of October 2009, net sales increased 4.9% to $104.1 million from $99.3 million in October a year earlier. For the two months ended October 31, 2009, net sales increased 3.7% to $200.0 million from $192.9 million in the same period last year. There were 26 warehouse clubs in operation at the end of October 2009, compared to 25 warehouse clubs in operation in October 2008. For the four weeks ended October 25, 2009, comparable warehouse sales for warehouse clubs open at least 12 full months decreased 0.3% compared to the same four-week period last year. For the eight-week period ended October 25, 2009, comparable warehouse sales decreased 0.7% compared to the comparable eight week period a year ago. | ||
| 08:02 | FSIN Fushi Intl reports EPS in-line, misses on revs; guides Q4 EPS in-line (6.90 ) | |
| Reports Q3 (Sep) earnings of $0.26 per share, excluding non-recurring items, in-line with the First Call consensus of $0.26; revenues fell 25.3% year/year to $47.7 mln vs the $55.4 mln consensus. Co issues in-line guidance for Q4, sees EPS of $0.26-0.30, excluding non-recurring items, vs. $0.29 consensus. | ||
| 07:58 | PMI PMI Group reports Q3 EPS of ($1.06) vs ($1.36) First Call consensus; revs rose 1% YoY to $226.9 mln vs $198.66 mln First Call consensus (2.23 ) | |
| The loss from continuing operations for the third quarter of 2009 was primarily driven by losses and loss adjustment expenses (LAE) in U.S. Mortgage Insurance Operations, decreases in U.S. Mortgage Insurance Operations' premiums earned and investment income, and the change of the fair value of certain holding company senior debt. | ||
| 07:37 | AIG American Intl trades down 9% in early trading following Q3 earnings... stock is now down 4 pts at 35.30 (39.28 ) -Update- | |
| 07:35 | SNI Scripps Networks Interactive beats by $0.03, reports revs in-line (39.23 ) | |
| Reports Q3 (Sep) earnings of $0.39 per share, $0.03 better than the First Call consensus of $0.36; revenues rose 0.1% year/year to $364.5 mln vs the $365.6 mln consensus. Total revenue from the company's portfolio of Lifestyle Media television networks, Web sites and other related businesses was up 4.3 percent for the period compared with last year. Results for the three-month period ended Sept. 30 reflect strong affiliate fee revenue growth and improved advertising sales at the company's flagship cable television networks, Food Network and HGTV. | ||
| 07:34 | DRQ Dril-Quip beats by $0.05, beats on revs; guides Q4 EPS in-line (52.57 ) | |
| Reports Q3 (Sep) earnings of $0.72 per share, excluding non-recurring items, $0.05 better than the First Call consensus of $0.67; revenues rose 4.5% year/year to $138.2 mln vs the $136.1 mln consensus. Co says that its backlog at September 30, 2009 was approximately $623 mln. Co issues in-line guidance for Q4, sees EPS of $0.62-$0.72 vs. $0.67 consensus. | ||
| 07:34 | PRX Par Pharmaceutical beats by $0.27, beats on revs (22.78 ) | |
| Reports Q3 (Sep) earnings of $0.76 per share, $0.27 better than the First Call consensus of $0.49; revenues rose 97.9% year/year to $294.8 mln vs the $290.5 mln consensus. The YoY increase in revenue was principally driven by limited competition in metoprolol succinate, sum succinate, meclizine, and dronabinol, as well as the launches of nategli clonidine in the third quarter. Gross margin for the third quarter 2009 was $92.1 million, or 31.3% of total revenue, an increase of $40.7 million from the comparable period in 2008 (consensus was for gross margin of 26%). Total generic gross margin in the third quarter 2009 was $72.9 million, or 27.1% of total generic revenue, compared to $35.9 million, or 27.8% of total generic revenue in the third quarter 2008. This increase is due primarily to higher sales of metoprolol coupled with the launches of sumatriptan, dronabinol, and clonidine, partially offset by lower sales of fluticasone and amoxicillin. Par currently has approximately 27 ANDAs pending with the FDA, 13 of which Par believes to be first-to-file and/or first-to-market opportunities with a brand value of approximately $6.5 billion. | ||
| 07:33 | LRN K12 beats by $0.01, reports revs in-line; guides FY10 revs above consensus (15.80 ) | |
| Reports Q1 (Sep) earnings of $0.24 per share, $0.01 better than the First Call consensus of $0.23; revenues rose 20.0% year/year to $106.3 mln vs the $106.1 mln consensus. Co issues upside guidance for FY10, sees FY10 revs of $380-$390 mln vs. $378.67 mln consensus. In addition, the company is forecasting for FY10, neet income for K12 Inc. of approximately $14.6- $17.1 mln. | ||
| 07:32 | KELYA Kelly Services misses by $0.11, beats on revs (11.91 ) | |
| Reports Q3 (Sep) loss of $0.35 per share, excluding legal charges of $0.08 per share, $0.11 worse than the First Call consensus of ($0.24); revenues fell 24.9% year/year to $1.05 bln vs the $1.02 bln consensus. "We are seeing signs that the global economy is picking up steam and job losses are stabilizing. In the past few months, trends have shown modest improvement, and we're particularly encouraged by the steady, sequential nature of that upturn... Employers are understandably concerned about the sustainability of this recovery and likely will be guarded about expanding their workforce." | ||
| 07:31 | CF CF Industries rejects latest revised proposal from Agrium (79.90 ) | |
| Co announces that its board of directors has rejected Agrium latest revised proposal to acquire all outstanding shares of CF Industries. Following a review of Agrium's latest revised proposal with management and its legal and financial advisors, the CF Industries board of directors concluded that the offer continues to substantially undervalue the company and is not in the best interests of CF Industries and its stockholders. | ||
| 07:16 | RXII RXi Pharmaceuticals appoints Noah D. Beerman as CEO (2.19 ) | |
| Co announces that Noah D. Beerman has joined the company as its new President and Chief Executive Officer. The appointment of Mr. Beerman as CEO is part of a planned succession in leadership as the company looks to advance from the research stage to product development and execution of therapeutic collaborations and partnerships. He succeeds RXi's co-founder, Tod Woolf, Ph.D., who will continue as a member of RXi's Scientific Advisory Board. Mr. Beerman joins RXi with over 25 years of experience in the biopharmaceutical industry and most recently served as Executive Vice President, Chief Business Officer for Indevus Pharmaceuticals. | ||
| 07:15 | AIG American Intl reports above consensus Q3 results (39.28 ) | |
| Reports Q3 (Sep) adjusted earnings of $2.85 per share, excluding non-recurring items, $0.87 better than the First Call consensus of $1.98. At September 30, 2009, total equity was $76.5 bln, a $14.4 bln increase from $62.1 bln at June 30, 2009. The increase includes $455 mln of net income attributable to AIG, $12.1 bln of unrealized appreciation of investments, $2.1 bln from a draw-down of the Department of the Treasury Commitment related to the Series F Fixed Rate Non-Cumulative Preferred Stock, partially offset by a $350 mln reduction in non-controlling interests. "Our results reflect continued stabilization in performance and market trends. AIG employees are working to preserve the strength of our insurance businesses in a challenging market by working closely with our distribution partners, with third quarter 2009 showing signs of stabilization. Pricing in our commercial property casualty business has been stable. Management continues to monitor rates closely and maintain underwriting discipline, turning away some renewal business due to aggressive pricing by existing and new competitors. At AIGFP, virtually all key risk measures are down significantly and the earnings again benefited from a positive unrealized market valuation gain on the Super Senior Credit Default Swap portfolio. Additionally, we announced the sales of Nan Shan and a portion of AIG's investment advisory and asset management business, as well as the combination of our Domestic Life Insurance & Retirement Services businesses and ongoing efforts to build their value as part of AIG... Improved market performance, together with application of the new investment impairment accounting standard adopted in the second quarter of 2009, drove a reduction in net realized capital losses compared to third quarter 2008 and positive valuation changes for our Maiden Lane Interests, as well as increases in partnership and mutual fund income. These gains were offset by impairments in the Asset Management segment, higher current accident year losses related to credit crisis exposures and prior accident year losses in General Insurance and lower income from Life Insurance & Retirement Services investment-linked and annuity products globally. When we close the special purpose vehicles with respect to AIA and ALICO with the Federal Reserve Bank of New York (FRBNY), we expect to recognize an approximate $5 bln charge for accelerated amortization of the prepaid commitment asset. These transactions are expected to close in the fourth quarter." | ||
| 07:09 | FIG Fortress Investment beats by $0.02, beats on revs (4.57 ) | |
| Reports Q3 (Sep) earnings of $0.11 per share, $0.02 better than the First Call consensus of $0.09; revenues fell 22.4% year/year to $143.7 mln vs the $123.2 mln consensus. | ||
| 07:09 | TNP Tsakos Energy beats by $0.08, beats on revs (15.09 ) | |
| Reports Q3 (Sep) earnings of $0.06 per share, $0.08 better than the First Call consensus of ($0.02); revenues fell 33.1% year/year to $106.2 mln vs the $80.9 mln consensus. | ||
| 07:08 | STT State Street updates Q3 2009 reported results to reflect increased reserve; operating outlook for 2009 remains unchanged (42.81 ) | |
| Co announced that it has added $250 million, as of September 30, 2009, to the reserve it established in 2007 to address legal exposure related to losses incurred by investors in certain active fixed-income strategies managed by State Street Global Advisors (SSgA). The Company believes the adjusted reserve should be sufficient to account for a potential resolution of proceedings by the Securities and Exchange Commission and other governmental authorities, and to address ongoing litigation with respect to this matter... State Street also announced that it recently entered into a settlement of the purported class action with respect to ERISA participants in the active fixed -income strategies. The proposed settlement of $89.75 million is subject to court approval. Prior to recording the $250 million provision for legal exposure, the legal reserve totaled $193 million. After giving effect to the $250 million provision, the reserve as of September 30, 2009, as adjusted is $443 million, and should be sufficient to settle the above matters, including the purported class action. For the third quarter of 2009, updated reported results are earnings per share of $0.66 on net income of $327 million (co originally reported $1.05 in EPS). Return on common shareholders' equity is 10.2%, down from the previously announced 16.0%. Operating-basis results for the third quarter of 2009 exclude the provision for legal exposure and are unchanged from the operating-basis results announced on October 20, 2009. State Street's outlook for the full-year 2009 remains unchanged with operating basis revenue expected to decline about 16 percent from the record level of 2008; operating earnings per share, excluding the impact of the extraordinary loss recorded upon consolidation of the commercial paper conduits in the second quarter of 2009, and the provision for legal exposure announced today, to be between $4.13 and $4.17 (consensus $4.11) and operating return on equity to be between 14-17%. | ||
| 07:07 | LPNT Lifepoint Hospitals beats by $0.03, beats on revs; reaffirms FY09 EPS guidance, revs guidance (29.00 ) | |
| Reports Q3 (Sep) earnings of $0.59 per share, $0.03 better than the First Call consensus of $0.56; revenues rose 10.4% year/year to $745 mln vs the $729.9 mln consensus. Co reaffirms guidance for FY09, sees EPS of $2.35-2.55 vs. $2.44 consensus; sees FY09 revs of $2.9-3.0 vs. $2.94 bln consensus. | ||
| 07:05 | DM Dolan Media beats by $0.04, beats on revs; raises FY09 EPS and rev guidance; acquires 85% interest in DiscoverReady (12.78 ) | |
| Reports Q3 (Sep) earnings of $0.20 per share, $0.04 better than the First Call consensus of $0.16; revenues rose 30.1% year/year to $62.3 mln vs the $61 mln consensus. Co raises guidance for FY09, sees EPS of $0.94-0.98 vs. $0.91 consensus, up from previous guidance of $0.83-0.91; sees FY09 revs of $260-263 mln vs. $258.37 mln consensus, up from previous guidance of $254-258.5 mln. Mortgage default processing services revenues increased $14.7 million in the third quarter of 2009 compared to third quarter of 2008, which is attributable to the Barrett-NDEx operations we acquired in September 2008... Professional Services Division revenues increased to 64.2% of total revenues for the third quarter of 2009, from 53.6% for the same prior-year period. Business Information Division revenues for the three months ended September 30, 2009, represented 35.8% of total revenues compared to 46.4% in the same period in 2008. This change in mix primarily resulted from a $16.9 million increase in revenues in the third quarter from Barrett-NDEx, as well as from general economic conditions in the markets we serve."... Co also announces it acquired an 85% equity interest in DiscoverReady, a provider of outsourced discovery management and fixed-fee document review services to major companies and their counsel. | ||
| 07:01 | ALNC Alliance Financial announces withdrawl of $25 mln offensive common stock offering due to market conditions (22.78 ) | |
| 07:01 | RURL Rural/Metro is launching a tender offer and consent solicitation for its outstanding 9.875% Senior Subordinated Notes due 2015 (4.95 ) | |
| 06:58 | RSCR Res-Care reports EPS in-line, misses on revs; reaffirms FY09 EPS guidance, revs guidance (11.90 ) | |
| Reports Q3 (Sep) earnings of $0.35 per share, in-line with the First Call consensus of $0.35; revenues rose 2.0% year/year to $395.8 mln vs the $401.6 mln consensus. Co reaffirms guidance for FY09, sees EPS of $1.30-1.34 vs. $1.32 consensus; sees FY09 revs of $1.60-1.63 bln vs. $1.61 bln consensus. | ||
| 06:55 | DYP Duoyuan Printing prices 6.5 mln share IPO at $8.50 per share; the low end of the expected range of $8.50-10.50 per share | |
| Co intends to use the net proceeds of approximately $42.3 mln to build a factory to manufacture cold-set corrugated paper machines at its Langfang Duoyuan facility, to improve and upgrade its existing manufacturing facilities and production lines and for general corporate purposes. | ||
| 06:38 | RMIX U.S. Concrete adopts section 382 stockholder rights plan to preserve use of net operating losses (1.22 ) | |
| Co announces its Board of Directors has adopted a Section 382 Stockholder Rights Plan designed to protect stockholder value by preserving the value of certain deferred tax assets of the Company primarily associated with new operating loss carryforwards under Section 382 of the Internal Revenue Code. The Company's ability to use its net operating losses and other tax benefits could be substantially reduced if an "ownership change" under Section 382 were to occur. An "ownership change" would occur if stockholders that own (or are deemed to own) at least 5% or more of the Company's outstanding stock increase their cumulative ownership by more than 50 percentage points over their lowest ownership percentage within a rolling three-year period. The Rights Plan was adopted to reduce the likelihood of an unintended "ownership change" occurring as a result of ordinary buying and selling of the Company's common shares. Similar plans have been adopted by a number of companies in the construction and homebuilding industry over the past year. | ||
| 06:37 | GSI General Steel beats by $0.12, beats on revs (3.92 ) | |
| Reports Q3 (Sep) earnings of $0.22 per share, $0.12 better than the First Call consensus of $0.10; revenues rose 17.8% year/year to $484.8 mln vs the $456.1 mln consensus. | ||
| 06:36 | BHI Baker Hughes announces October 2009 Rig Counts (42.12 ) | |
| Co announces the international rig count for October 2009 was 983, down 3 from the 986 counted in September 2009, and down 113 from the 1,096 counted in October 2008. The international offshore rig count for October 2009 was 267, down 8 from the 275 counted in September 2009 and down 17 from the 284 counted in October 2008 | ||
| 06:35 | AER AerCap signs agreements for $358 mln of funding for Airbus A330s (8.90 ) | |
| Co announces it has signed a series of agreements with China Development Bank which provides funding for $86 million of pre-delivery payments and a $272 million long term funding facility covering four new Airbus A330 aircraft with deliveries scheduled in 2010 and 2011. The four aircraft are part of AerCap's 30 A330 order placed in 2006/2007 with deliveries scheduled until 2012. | ||
| 06:35 | ME Mariner Energy misses by $0.13, misses on revs (13.20 ) | |
| Reports Q3 (Sep) earnings of $0.04 per share, $0.13 worse than the First Call consensus of $0.17; revenues fell 28.5% year/year to $227.3 mln vs the $247.4 mln consensus. The lower year-over-year results are due primarily to lower commodity prices. "During the third quarter, production increased in the deepwater and onshore, but construction delays temporarily deferred growth from the shelf. Mariner's capital spending for 2009 should be less than half of 2008's, but we expect to achieve a year-over-year production increase of approximately 10% to 128 - 130 Bcfe, as well as strong cash flow and excellent liquidity. We have continued to expand and diversify our opportunity set, most recently in the deepwater and onshore, including our entry into unconventional resources." | ||
| 06:34 | AMRN Amarin appoints John F. Thero as Chief Financial Officer (1.37 ) | |
| 06:31 | GOK Geokinetics misses by $0.33, misses on revs (18.05 ) | |
| Reports Q3 (Sep) loss of $0.41 per share, excluding $0.04 in severance costs, $0.33 worse than the First Call consensus of ($0.08); revenues fell 21.4% year/year to $96.8 mln vs the $133.9 mln consensus, with gross margins at 31% vs 23% last yr. The decline in revenues was primarily attributable to further weakness in North America as evidenced by third quarter 2009 international seismic acquisition revenues declining by less than 2% from the third quarter of 2008. While lower global prices for oil and natural gas have tempered exploration spending during the past year, the international job mix has been shifting to shallow water marine and transition zone acquisition, areas where the Company operates very effectively. Geokinetics' backlog as of September 30, 2009 was approximately $259 million, down 49% from $509 million at September 30, 2008 and down 19% from $318 million at June 30, 2009. | ||
| 06:23 | S&P futures vs fair value: -0.30. Nasdaq futures vs fair value: +1.00. | |
| 06:23 | Asian Markets | |
| Nikkei...9789.35...+71.90...+0.70%. Hang Seng...21829.72...+350.60...+1.60%. | ||
| 06:23 | European Markets | |
| FTSE...5135.15...+9.50...+0.20%. DAX...5484.08...+3.20...0.00. | ||
| 06:12 | SUP Superior Ind misses by $0.34, beats on revs (13.79 ) | |
| Reports Q3 (Sep) loss of $0.48 per share, $0.34 worse than the First Call consensus of ($0.14); revenues fell 31.8% year/year to $111.4 mln vs the $106.8 mln consensus. Unit shipments decreased 9.7% in the 2009 third quarter compared with the same period a year ago. Average selling prices decreased approximately 23.8% compared with the prior year, due principally to a reduction in the pass-through pricing of aluminum. Gross profit was $4.2 million, or 3.8% of net sales, in the third quarter of 2009, compared to gross loss of $11.2 million, or 6.9% of net sales, for the third quarter of 2008. "We are encouraged by the production volume increases that materialized as the third quarter progressed. While a significant portion of the increase was attributed to the post bankruptcy reorganizations at General Motors and Chrysler, orders with virtually all of our customers increased in the third quarter. Based on orders received thus far, we believe that our sales will show moderate improvement during the fourth quarter" (consensus calls for 21% QoQ rev growth). | ||
| 06:07 | EXLS ExlService beats by $0.08, beats on revs; raises FY09 rev guidance (13.86 ) | |
| Reports Q3 (Sep) earnings of $0.14 per share, $0.08 better than the First Call consensus of $0.06; revenues rose 3.4% year/year to $48.2 mln vs the $44.5 mln consensus. Co raises guidance for FY09, sees FY09 revs of $178-180 mln vs. $174.14 mln consensus, up from previous guidance of $170-175 mln; with adjusted operating margin, ex-items, of 13.0% and 13.5% from 10.0% and 12.0%. Gross margin for the quarter ended September 30, 2009 was 40.2% compared to 39.8% for the quarter ended September 30, 2008 and 39.1% for the quarter ended June 30, 2009. adjusted operating margin for the quarter ended September 30, 2009, excluding the impact of stock-based compensation expense and amortization of intangibles, was 14.8% compared to 14.7% for the quarter ended September 30, 2008 and 11.3% for the quarter ended June 30, 2009. | ||
|
||
| 18:58 | GB Wilson Greatbatch misses by $0.04, misses on revs; guides FY09 revs below consensus (20.23 +0.68) | |
| Reports Q3 (Sep) earnings of $0.32 per share, excluding non-recurring items, $0.04 worse than the First Call consensus of $0.36; revenues fell 10.8% year/year to $121.5 mln vs the $133.5 mln consensus. Co issues downside guidance for FY09, sees FY09 revs of $520-535 mln vs. $555.48 mln consensus. Co said, "Despite this lower revenue, we still believe our adjusted operating income for the full year 2009 will be in line with our previously provided guidance of 11.0% to 13.0% of sales due to our on-going consolidation and cost-cutting initiatives. | ||
| 18:56 | PMT PennyMac Mortgage misses by $0.08, misses on revs (18.58 +0.17) | |
| Reports Q3 (Sep) loss of $0.04 per share, $0.08 worse than the First Call consensus of $0.04. Co reported revs of $0.816 mln vs. 2.25 mln consensus. | ||
| 18:53 | CPE Callon Petroleum beats by $0.06, beats on revs (1.78 +0.11) | |
| Reports Q3 (Sep) loss of $0.04 per share, $0.06 better than the First Call consensus of ($0.10); revenues fell 35.1% year/year to $21.3 mln vs the $20.7 mln consensus. | ||
| 18:09 | BMY Bristol-Myers: FDA approves labeling update for REYATAZ (atazanavir sulfate) capsules to include 96-week data for previously untreated HIV-1 infected adult patients (22.50 +0.32) | |
| Co announced that the U.S. Food and Drug Administration has approved a labeling update for REYATAZ(R) to include long-term data from the CASTLE Study. The CASTLE Study assessed a once-daily REYATAZ/ritonavir (REYATAZ/r)-based regimen versus a twice-daily lopinavir/ritonavir (LPV/r)-based regimen in previously untreated adult patients infected with HIV-1. Data from the study demonstrate enduring virologic response through 96 weeks of treatment with REYATAZ/r as part of combination therapy. | ||
| 18:07 | PSA Public Storage beats by $0.19, misses on revs (76.69 +2.00) | |
| Reports Q3 (Sep) funds from operations of $1.44 per share, $0.19 better than the First Call consensus of $1.25; revenues fell 4.6% year/year to $352.1 mln vs the $405.1 mln consensus. | ||
| 18:00 | FLR Fluor wins new Iraq contracts from U.S. Army Corps of Engineers; contracts are valued in total at ~$80 mln (45.25 +0.30) | |
| 17:56 | TC Thompson Creek announces 30% increase in molybdenum mineral reserves and new 16-year mine plan for Thompson Creek Mine (11.01 +0.22) -Update- | |
| Co announced new estimates for mineral resources and reserves and a new 16-year mine plan at its Thompson Creek Mine in Idaho. The new estimates are based on definition drilling conducted at the mine since the previous estimates were published in 2007. Co said, "The drilling results are a positive development for the co. We found additional mineable areas, particularly within the western wall of the existing pit, resulting in a 30% increase in contained molybdenum in proven and probable mineral reserves compared with the 2007 estimate. As a result, we have adopted a new 16-year mine plan to replace the previous 10-year plan. Adjusting for differing molybdenum price forecasts, starting points and mining production schedules, the economic value of the new plan exceeds that of the old." The new mine plan, which replaces a previous 10-year plan published in 2007, calls for the production of 247.6 mln pounds of molybdenum over 16 years and is based on a pit design including previously planned Phases 6 and 7 and a revised Phase 8. Phase 8 had previously focused on mining reserves in the east wall of the pit but has been revised to include the mining of added proven and probable mineral reserves identified by definition drilling in the west wall of the pit. The new mine plan assumes a return to full capacity utilization of the mill at the Thompson Creek Mine by January 2010. The mill's production rate was reduced to ~70% of full capacity in March 2009 due to economic conditions. The co announced on November 5, 2009 that the mill has been operating at 78% of full capacity since September 2009 and is scheduled to operate at full capacity in January 2010. | ||
| 17:56 | SCI Service Corporation International announces pricing of senior notes offering (7.51 +0.62) -Update- | |
| Co announced that it has priced an underwritten public offering of $150.0 million of senior notes due 2021, which will bear interest at a rate of 8.00% per annum. The notes are being sold at 98.115% of par, which equates to an effective yield to maturity of ~8.25%. | ||
| 17:42 | HA Hawaiian Airlines reports October traffic statistics (6.82 +0.16) | |
| Co reported October RPMS growth of 5.7% to 680,709, ASMS growth of 2.6% to $797,707. | ||
| 17:40 | KGC Kinross announces unsecured US$450 mln credit facility (18.75 -0.11) | |
| Co announced that it has entered into an amended revolving credit facility which includes an increase of available credit to US$450 mln, on an unsecured basis, from US$404 mln under its previous secured facility. The new facility will expire in November of 2012. The term loan for the Paracatu property forms part of the revolving credit facility, and that credit will be available to the co as the term loan is repaid | ||
| 17:39 | CVI CVR Energy announced that one of its stockholders has commenced a registered underwritten public offering of 7,376,264 shares of CVR Energy's common stock; the co will not receive any of the proceeds of the offering (10.31 -0.01) | |
| 17:37 | NCMI National Cinemedia files registration statement of 59.4 mln shares of common stock (15.16 -0.15) -Update- | |
| 17:35 | MXB MSCI Inc. announces pricing of public offering of 3.3 mln shares of its common stock at $30.85 (30.92 +0.66) -Update- | |
| 17:31 | MHK Mohawk Announces Wellborn Appointed President and COO (43.48 +1.86) | |
| The co announces the appointment of W. Christopher Wellborn to President and COO of Mohawk. Mr. Wellborn has held the position of Chief Operating Officer since November 2005 and served on Mohawk's board of directors since 2002. Mr. Wellborn held the position of President of Dal-Tile, our ceramic and stone products business, from March 2002 to November 2005. | ||
| 17:29 | D Dominion reaffirms 2009 and 2010 EPS inline with consensus; co reaches comprehensive proposed settlement (35.81 +0.71) | |
| Co says, with the announcement of the proposed settlement and its limited sensitivity to commodity price changes it is reaffirming 2009 operating EPS of $3.20-3.30 vs. $3.24 First Call consensus; co also reaffirms 2010 operating EPS of $3.20-3.40 vs. $3.24 consensus. Co says, "the proposed settlement was within the range of possible outcomes we anticipated when we revised our operating earnings outlook in July. We will be in a better position to provide details for 2010 after we receive a final order in the Virginia base rate case proceeding." | ||
| 17:14 | HME Home Prop of NY beats by $0.03, reports revs in-line; guides Q4 FFO in-line (40.37 +1.46) | |
| Reports Q3 (Sep) funds from operations of $0.81 per share, $0.03 better than the First Call consensus of $0.78; revenues rose 2.0% year/year to $126.3 mln vs the $125.5 mln consensus. Co issues in-line guidance for Q4, sees FFO of $0.73-0.79 vs. $0.76 consensus. "Home Properties exceeded both internal and street expectations for Funds From Operations in the third quarter, reflecting the stability of our solid geographic markets and middle-market apartment properties, even in a challenging operating environment," said Edward J. Pettinella, President and CEO. "Our number one ranking in same-unit net operating income growth in the apartment sector results from a continued focus on managing rents to optimize occupancy and revenue, while also controlling costs and refining operations to ensure excellent future results despite continued weakness in the economy." | ||
| 17:14 | EOG EOG Resources beats by $0.15, misses on revs (88.03 +2.73) | |
| Reports Q3 (Sep) earnings of $0.81 per share, excluding non-recurring items, $0.15 better than the First Call consensus of $0.66; revenues fell 69.2% year/year to $1.01 bln vs the $1.13 bln consensus. Based on the performance of its North American liquids plays, EOG has increased its 2009 total co production growth target from 5.5-6%. For 2010, EOG has set a total company organic production growth target of 13% that includes total liquids production growth of 50%. | ||
| 17:12 | VLO Valero Energy: Records a loss of contingency accrual of $~140 mln in Q3 results (12.72 +0.02) | |
| The co announces that an arbitration panel in the Netherlands handed down an interim decision on certain issues in dispute between Valero and the Government of Aruba. The panel ruled favorably on Valero's existing exemption from income tax liability for refining operations through 2010. Two other items in the arbitration - the applicable dividend tax rate and the turnover tax - were not fully resolved in the panel's decision and remain subject to further review. Valero continues to believe that its remaining claims against these taxes have significant merit, and intends to vigorously pursue these claims through the arbitration proceedings and in proceedings in Aruba. Valero had not recognized any expense or liability with respect to these matters in its consolidated financial statements or in the company's third quarter earnings release issued Oct. 27, 2009. Due to the uncertain timing of the panel's final ruling, the company has recorded a loss contingency accrual of approximately $140 million, or $(0.25) per share, in its financial results for the quarter ended Sept. 30, 2009. The accrual includes all material liabilities through Sept. 30, 2009 associated with the arbitration. | ||
| 17:12 | NFG National Fuel Gas misses by $0.03, misses on revs (47.47 ) | |
| Reports Q4 (Sep) earnings of $0.36 per share, $0.03 worse than the First Call consensus of $0.39; revenues fell 29.9% year/year to $278.9 mln vs the $361.5 mln consensus. | ||
| 17:09 | OHB Orleans Homebuilders announces limited waiver and amendment extension (2.26 -0.08) | |
| Co announces that as of October 30, 2009, the Company had received from the lenders under the Company's $375 mln Credit Facility a limited waiver and amendment extension letter related to the Company's Second Amended and Restated Revolving Credit Loan Agreement dated September 30, 2008. The Limited Waiver and Amendment Extension Letter effectively extends for approximately one month the borrowing base relief, minimum liquidity covenant deferral, existing loan fee payment deferral and other accommodations provided by the terms of the Third Amendment executed on September 30, 2009. In addition, the Limited Waiver and Amendment Extension Letter waives a number of specific events of default and anticipated events of default under the Credit Agreement. | ||
| 17:08 | MAA Mid-America Aptmt beats by $0.03, beats on revs, issues Q4 FFO guidance (45.10 +1.15) | |
| Reports Q3 (Sep) Funds from Operations (FFO) of $0.89 per share, $0.03 better than the First Call FFO consensus of $0.86; revenues rose 0.7% year/year to $94.4 mln vs the $92.9 mln consensus. Co guides FFO per diluted share/unit for the fourth quarter of 2009 in the range of $0.82 to $0.92 vs $0.84 consensus. Management will continue to address the anticipated future needs for additional debt or equity based on its evaluation of external growth opportunities. Full-year same store NOI is projected to decline 1.5% to 3.0%, compared to the prior forecast of 2.5% to 4.5%. Same store revenues are forecasted to decline in a range of 1% to 2% compared to the prior year. Guidance continues to include $75 million of wholly-owned acquisitions and $30 million of dispositions for the full year of 2009. Guidance currently includes $50 million of acquisitions for the new joint venture for the full year of 2009, as compared to $75 million projected at the end of the second quarter. The average interest rate for 2009 continues to be projected at 4.4%. | ||
| 17:08 | MGA Magna beats by $0.64, beats on revs (44.20 +0.62) | |
| Reports Q3 (Sep) earnings of $0.45 per share, $0.64 better than the First Call consensus of ($0.19); revenues fell 15.6% year/year to $4.67 bln vs the $4.53 bln consensus. "Our Board of Directors has approved the redemption of all of our outstanding 6.5% Convertible Subordinated Debentures (the "Debentures") for cash on December 7, 2009. The Debentures are redeemable at a price equal to 100% of the principal amount of the Debentures to be redeemed, plus accrued and unpaid interest thereon to, but excluding, the date of redemption. The aggregate principal amount of Debentures currently outstanding is Cdn. $99,998,000." | ||
| 17:04 | IPI Intrepid Potash reports EPS in-line, beats on revs; expects that potash prices may trend downward somewhat going into Q4 (27.35 +0.70) | |
| Reports Q3 (Sep) earnings of $0.13 per share, in-line with the First Call consensus of $0.13; revenues fell 54.6% year/year to $66.4 mln vs the $64.5 mln consensus. The average net realized sales price for potash in Q3 2009 was $458 per short ton ($505 per metric ton) compared to $623 per short ton ($687 per metric ton) in the same period of 2008. Co said, "The Q3 began to show some signs of a moderate recovery in the domestic potash market. Although the potash market in the United States remains a just-in-time market, our forward warehousing efforts have provided Intrepid the opportunity to participate in sales that we would have otherwise not realized. With the fall harvest going slowly, we believe that the persistent wet weather through October in much of the corn growing regions will reduce the chance of a return to normal or near normal fertilization levels until the spring... The 111,000 short tons of potash we sold in Q3 of 2009 was at an average net realized sales price, which we define as gross sales less freight costs, of $458 per short ton as compared to an average net realized sales price of $623 per short ton during the third quarter of 2008. As price discussions continue to occur in our markets and the fall application window narrows, we expect that price may trend downward somewhat as we enter Q4." |
||
| 17:01 | ACM Aecom Tech announces that it has acquired SSI Services (25.90 +0.51) | |
| Co announces that it has acquired SSI Services from the Vanadium Group. The acquisition strengthens AECOM's service offerings in critical-mission environments such as federal facilities that have limited access as well as strict safety and security requirements. | ||
| 17:00 | ETQ Corriente Resources announces that President Correa has signed the Regulations to the Mining Law (6.08 +0.17) | |
| Co announces that President Correa has signed the Regulations to the Mining Law that was proclaimed earlier this year. The ceremony for the Presidential approval was held on Wednesday, November 4, 2009 in Zaruma, Ecuador which is an important center for the small mining industry in Ecuador. "With the Regulations signed, real progress has been made in the development of a responsible mining sector in Ecuador. Corriente now will be able to carry out advanced development work on our projects under these new Regulations. We expect a significant increase in opportunities for members of our local communities who are the key stakeholders in a future which encompasses responsible mining. With the price of copper doubling since the beginning of the year as the global economy recovers, the outlook for the Company's projects has improved materially." Negotiations still continue with the selected party regarding the potential sale of the company as last reported in the Company's news release dated July 20, 2009. The extension of these discussions with the selected party has presented the company with an opportunity to respond to renewed interest we are receiving in our copper projects in Ecuador. Several groups have completed their review of project information in the company's data room and requests have been received for Ecuador site visits. Corriente intends to take advantage of this newly improved copper environment to ensure shareholders are presented with the best outcome. | ||
| 16:57 | AFG American Fincl announces that the Board has authorized the repurchase of up 5 mln additional shares (24.90 +0.55) | |
| The co announces that its Board of Directors has authorized the repurchase of up to an additional five million shares of the Company's outstanding common stock. This authorization is in addition to the 1.25 million shares remaining at September 30, 2009 from the Board's previous repurchase program authorized in August 2007. The Company currently has approximately 116 million shares of common stock outstanding. | ||
| 16:54 | KOG Kodiak Oil & Gas reports Q3 EPS of $0.00 vs $0.00 First Call consensus; revs $3.74 mln vs $3.91 mln First Call consensus (2.48 +0.05) | |
| 16:53 | EGAS Energy announces acquisition of Cut Bank Gas Company (9.10 +0.01) | |
| Co announces that its subsidiary Energy West has completed the acquisition of approximately 83% of the outstanding shares of Cut Bank Gas Company, a natural gas utility serving Cut Bank, Montana. | ||
| 16:52 | REXX Rex Energy reports Q3 EPS of ($0.06) vs ($0.05) First Call consensus; revs $13.1 mln vs $14.20 mln First Call consensus (8.68 +0.38) | |
| "We are continuing to accelerate our production growth due primarily to our Marcellus Shale exploration. Natural gas production was up 62% over the same period in 2008 and up 29% compared to the second quarter 2009, despite experiencing continued pipeline related production curtailments. During the third quarter, a portion of our natural gas production from our conventional wells was shut-in due to third party line maintenance, which effectively reduced our average daily natural gas sales by approximately 17%." | ||
| 16:51 | GROW U.S. Global Investors reports Q1 net income of $0.09 per share on revenue of $8.0 mln; single analyst estimate $0.06 and $6.55 mln respectively (9.34 +0.70) | |
| Sequentially, the latest quarter improves on the earnings of $1.0 million, or 6 cents per diluted share, on revenue of $6.5 million in the fourth quarter of fiscal year 2009. | ||
| 16:49 | VRTU Virtusa beats by $0.02; reports revs in line; guides Q3 EPS and revs in-line; guides FY10 EPS and revs in-line (9.11 +0.45) | |
| Virtusa prelim $0.12 vs $0.10 First Call consensus; revs down 15% YoY $37.5 mln vs $37.10 mln First Call consensus. Co sees Q3 $0.09-0.12 vs $0.14 First Call consensus; sees revs $39.7-41.4 mln vs $39.80 mln First Call consensus. Co sees FY10 $0.46-0.53 vs $0.51 First Call consensus; sees revs $157-162 mln vs $157.12 mln First Call consensus. "During the second quarter, the underlying business environment showed signs of improvement while the pace of the recovery remains measured. We started work with seven new clients as a result of our focus on accelerating business outcomes and reducing overall IT costs." | ||
| 16:46 | THLD Threshold Pharma reports net loss of $6.2 mln compared to $4.6 mln (2.66 +0.01) | |
| Threshold recognized no revenue in the quarter ended September 30, compared to $0.4 million for the quarter ended September 30, 2008. | ||
| 16:42 | TS Tenaris beats by $0.02, misses on revs (39.56 ) | |
| Reports Q3 (Sep) earnings of $0.39 per share, $0.02 better than the First Call consensus of $0.37; revenues fell 42.4% year/year to $1.77 bln vs the $1.88 bln consensus. | ||
| 16:42 | XIDE Exide Tech beats by $0.06, beats on revs (7.02 +0.52) | |
| Reports Q3 (Sep) loss of $0.11 per share, $0.06 better than the First Call consensus of ($0.17); revenues fell 30.9% year/year to $631.8 mln vs the $615.6 mln consensus. Gross margin for the fiscal 2010 second quarter increased 290 basis points to 20.6% from 17.7% in the prior year period and sequentially improved from the fiscal 2010 first quarter of 18.0% by approximately 260 bps. | ||
| 16:41 | ECLP Eclipsys beats by $0.01, misses on revs; guides FY09 EPS in-line (19.56 +0.78) | |
| Reports Q3 (Sep) earnings of $0.14 per share, $0.01 better than the First Call consensus of $0.13; revenues fell 5.2% year/year to $125.5 mln vs the $133.4 mln consensus. Co issues in-line guidance for FY09, sees EPS of $0.55-0.60 vs. $0.59 consensus. | ||
| 16:38 | ACTS Action Semi promotes Niccolo Chen to Chief Executive Officer (2.50 +0.03) -Update- | |
| Co announces that Niccolo Chen, Chief Strategy Officer and General Manager, has been promoted to the position of Chief Executive Officer as Nan-Horng Yeh steps down from this position to pursue personal interests. Mr. Yeh will remain a board member. Additionally, the Board appointed Robin Pan as an independent director. | ||
| 16:37 | ECLP Eclipsys reports non-GAAP net income of $0.14 per share, First Call consensus is $0.13; reports Q3 revenues of $125 mln, compared to $133 mln First Call consensus (19.56 +0.78) -Update- | |
| 16:35 | ECLP Eclipsys: North Mississippi Medical Center Selects Eclipsys to Enhance System-Wide Clinical Technology (19.56 +0.78) | |
| Co announces that North Mississippi Medical Center, a 650-bed regional referral center located in Tupelo, MS, has selected the Eclipsys' Sunrise Enterprise integrated suite of solutions. The major technology upgrade, which represents one of the largest contracts in recent Eclipsys company history, will span NMMC's seven acute care facilities to enhance the quality of system-wide electronic health records for faster, more informed clinical decision making. | ||
| 16:34 | SAM Boston Beer Co resumes trading (37.44 +0.48) -Update- | |
| 16:33 | GEOI GeoResources reports Q3 EPS of $0.46 compared to $1.14 in prior year, First Call ocnsensus $0.17; reports Q3 revenues of $22.9 mln compared to $23.5 mln in prior year, First Call consensus $19.4 mln (11.48 +0.34) | |
| 16:33 | SEM Select Medical beats by $0.05, reports revs in-line (10.00 +0.11) | |
| Reports Q3 (Sep) earnings of $0.09 per share, excluding non-recurring items, $0.05 better than the First Call consensus of $0.04; revenues rose 5.1% year/year to $545.6 mln vs the $542 mln consensus. | ||
| 16:33 | C Citigroup announces filing of registration statement for Primerica IPO (4.05 +0.09) | |
| Co announces that its subsidiary, Primerica, has filed a registration statement with the SEC for an initial public offering. After completion of this offering, Citi intends to divest its remaining interest in Primerica as soon as is practicable, | ||
| 16:32 | SWKS Skyworks beats by $0.02, beats on revs; guides Q1 EPS above consensus, revs above consensus (10.97 +0.64) | |
| Reports Q4 (Sep) earnings of $0.24 per share, excluding non-recurring items, $0.02 better than the First Call consensus of $0.22; revenues fell 1.9% year/year to $228.1 mln vs the $222.3 mln consensus. Co issues upside guidance for Q1, sees EPS of $0.25, excluding non-recurring items, vs. $0.22 consensus; sees Q1 revs of $238-242 mln vs. $230.77 mln consensus. "Skyworks' improving financial performance reflects the growing momentum of the mobile internet and increasing demand for always-on connectivity, particularly given the ubiquity of social networking applications and the proliferation of smart phones, notebooks, netbooks and embedded wireless devices. At a higher level, we believe we are at the beginning of three powerful, multi-year waves including broadband access growth, infrastructure capacity expansion and smart grid implementations. Skyworks is leading the way through analog semiconductor innovation, enabling better battery performance, signal quality and network coverage. As a result, we are entering a new and exciting growth phase which is positioning Skyworks to further differentiate, demonstrate even greater operating leverage, and most importantly, create shareholder value." | ||
| 16:32 | MCHX Marchex beats by $0.01, beats on revs (4.67 +0.15) | |
| Reports Q3 (Sep) earnings of $0.03 per share, ex-items, $0.01 better than the First Call consensus of $0.02; revenues fell 40.3% year/year to $22.2 mln vs the $20.4 mln consensus. Co states, "While there are some signs of stabilization and growth in core products, we continue to experience an advertising environment with shorter-term visibility as compared to prior years. As a result, we believe it prudent to not issue guidance at this time. Despite these factors, Marchex continues to generate cash every quarter and has no debt." | ||
| 16:32 | IVN Ivanhoe Mines Australia's Merlin Molybdenum and Rhenium deposit at Cloncurry receives initial NI 43-101 mineral Eesource Estimate (11.92 +0.33) | |
| Co announces that it has received an initial, independent NI 43-101 Resource Estimate for the high-grade Merlin molybdenum and rhenium deposit, which comprises part of Ivanhoe Australia's Mt. Dore Project in the Cloncurry District in northwestern Queensland. The Mo-Re mineralization represents a new discovery, now known as the Merlin deposit. Drilling is ongoing at the Merlin deposit to expand the zone of high-grade molybdenite and rhenium mineralization along strike and to depth. | ||
| 16:31 | KMB Kimberly-Clark announces regulatory clearance for its planned acquisition of I-Flow (63.55 +0.90) -Update- | |
| 16:30 | UNM Unum adds H1N1 vaccine to wellness benefit in critical illness policies (19.20 +0.02) | |
| Co announces that it has enhanced the wellness benefit of its critical illness products by adding the H1N1 vaccine to the list of qualifying procedures. | ||
| 16:29 | NVDA NVIDIA beats by $0.09, beats on revs; guides Q4 revs above consensus (12.27 +0.29) | |
| Reports Q3 (Oct) earnings of $0.19 per share, excluding non-recurring items, $0.09 better than the First Call consensus of $0.10; revenues rose 0.6% year/year to $903.2 mln vs the $838.1 mln consensus. NVIDIA prelim reports gross margin 41% vs 37.3% consensus. Co issues upside guidance for Q4, sees Q4 revs expected to be up slightly, approximately 2 percent, from the third quarter, equates to $921 mln vs. $868.11 mln consensus. "Revenue was up from a year ago, with improvement in each of our PC, professional solutions and consumer businesses. It's great to see us shipping orders with our Tegra mobile-computing solution, and growing enthusiasm for our Tesla platform for parallel computing in the server and cloud-computing markets." | ||
| 16:28 | ENOC EnerNOC beats by $0.47, beats on revs; guides Q4 EPS below consensus, revs below consensus (30.98 +1.30) | |
| Reports Q3 (Sep) earnings of $1.21 per share, $0.47 better than the First Call consensus of $0.74; revenues rose 133.3% year/year to $103.1 mln vs the $94.7 mln consensus. Co issues downside guidance for Q4, sees EPS of ($0.71)-($0.63) vs. ($0.61) consensus; sees Q4 revs of $23-25 mln vs. $25.47 mln consensus. | ||
| 16:27 | UEIC Univ Elec beats by $0.01, beats on revs; guides Q4 EPS below consensus, revs in-line (21.17 +1.10) | |
| Reports Q3 (Sep) earnings of $0.30 per share, $0.01 better than the First Call consensus of $0.29; revenues rose 8.8% year/year to $83.2 mln vs the $80 mln consensus. Co issues guidance for Q4, sees EPS of $0.38-0.42 vs. $0.47 consensus; sees Q4 revs of $81-84 mln vs. $83.57 mln consensus. | ||
| 16:26 | EBS Emergent Biosolutions misses by $0.03, misses on revs; reaffirms FY09 revs guidance (15.52 -0.02) | |
| Reports Q3 (Sep) earnings of $0.03 per share, $0.03 worse than the First Call consensus of $0.06; revenues fell 23.5% year/year to $43.3 mln vs the $49.6 mln consensus. Co reaffirms guidance for FY09, sees FY09 revs of $225-$240 mln vs. $234.03 mln consensus. | ||
| 16:26 | NHWK Nighthawk Radiology beats by $0.01, beats on revs; guides Q4 EPS below consensus, revs below consensus (6.76 +0.30) | |
| Reports Q3 (Sep) earnings of $0.17 per share, excluding non-recurring items, $0.01 better than the First Call consensus of $0.16; revenues rose 0.1% year/year to $43.5 mln vs the $42.7 mln consensus. Co issues downside guidance for Q4, sees EPS of $0.08-0.10 vs. $0.15 consensus; sees Q4 revs of $38-40 mln vs. $40.13 mln consensus. | ||
| 16:26 | CHH Choice Hotels beats by $0.05, reports revs in-line; guides Q4 EPS below consensus (31.59 +0.64) | |
| Reports Q3 (Sep) earnings of $0.56 per share, excluding non-recurring items, $0.05 better than the First Call consensus of $0.51; revenues fell 13.2% year/year to $166 mln vs the $166.5 mln consensus. Co issues downside guidance for Q4, sees EPS of $0.40, excluding non-recurring items, vs. $0.43 consensus. The company expects net domestic unit growth of approximately 4.0% in 2009; RevPAR is expected to decline approximately 12% for the fourth quarter of 2009 and decline between 13% and 14% for full-year 2009. The uncertainty around the current economic environment and credit market conditions and their impact on travel patterns and hotel development activities makes it difficult to predict future results, particularly as they relate to underlying assumptions for RevPAR, new hotel franchise and relicensing sales and interest and investment income and expense. | ||
| 16:25 | ICFI ICF International beats by $0.02, reports revs in-line; guides Q4 EPS in-line, revs below consensus; guides FY10 revs in-line (28.64 +0.17) | |
| Reports Q3 (Sep) earnings of $0.32 per share, $0.02 better than the First Call consensus of $0.30; revenues rose 44.2% year/year to $167.1 mln vs the $168.2 mln consensus. Co issues guidance for Q4, sees EPS of $0.30-$0.33 vs. $0.33 consensus; sees Q4 core revs of $165-$170 mln, may not compare to $170.30 mln consensus. Co issues in-line guidance for FY10, sees FY10 revs of $715-$750 mln vs. $730.78 mln consensus. Backlog was $1.4 bln at the end of 3Q09, up from $1.2 bln at the end of the prior quarter. Funded backlog was $556 mln, or 38.8% of the total. | ||
| 16:25 | MOVE Move misses by $0.02, misses on revs; guides Q4 revs below consensus; guides FY10 revs below consensus (1.91 +0.02) | |
| Reports Q3 (Sep) net of breakeven, $0.02 worse than the First Call consensus of $0.02; revenues fell 13.6% year/year to $52.9 mln vs the $54.7 mln consensus. Co issues downside guidance for Q4, sees Q4 revs of $47-48 mln vs. $54.60 mln consensus. Co issues downside guidance for FY10, sees FY10 revs of $184-192 mln vs. $230.70 mln consensus. | ||
| 16:24 | KNOT The Knot misses by $0.01, reports revs in-line (10.44 +0.31) | |
| Reports Q3 (Sep) earnings of $0.02 per share, $0.01 worse than the First Call consensus of $0.03; revenues rose 4.4% year/year to $28.2 mln vs the $28.5 mln consensus. | ||
| 16:24 | BGP Borders Group announces they will close ~ 200 Waldenbooks mall stores in January, leaving 130 mall-based locations open | |
| Co announces that as part of Borders Group's ongoing strategy to right-size its Waldenbooks Specialty Retail segment and emerge with a smaller, more profitable mall chain in fiscal 2010, the retailer will close approximately 200 mall stores in January, leaving approximately 130 mall-based locations open. With the store closings in January, approximately 1,500 positions--the majority of which are part-time jobs--will be eliminated. Employees have been informed of the right-sizing plan and efforts will be made to place qualified individuals in other positions within Borders Group. Displaced employees will receive severance. | ||
| 16:23 | SBUX Starbucks beats by $0.03, beats on revs; guides FY09 EPS above consensus | |
| Reports Q4 (Sep) earnings of $0.24 per share, $0.03 better than the First Call consensus of $0.21; revenues fell 3.7% year/year to $2.42 bln vs the $2.39 bln consensus. Non-GAAP operating margin improved 570 basis points y/y to 10.4%, previous quarter was 10.6%. Co delivered cost savings of $580 mln for FY09, above its target of $550 mln. Co had restrucutring charges of $53 mln in the quarter compared to $51.6 mln in Q3. Same store sales decline 1.0% compared to street expectations of -2.6%. Co issues upside guidance for FY09, sees EPS of $0.80 vs. $0.76 consensus. Co raises operasting margins target improvement y/y to 200-250 bps from 150-200 bps. Says it expects to see little impact from commodities in 2010. | ||
| 16:22 | LPSN LivePerson beats by $0.02, beats on revs; guides Q4 EPS in-line, revs above consensus (5.11 +0.09) | |
| Reports Q3 (Sep) earnings of $0.08 per share, $0.02 better than the First Call consensus of $0.06; revenues rose 14.9% year/year to $22.3 mln vs the $21.6 mln consensus. Co issues mixed guidance for Q4, sees EPS of $0.06-0.07, excluding non-recurring items, vs. $0.06 consensus; sees Q4 revs of $23.4-23.7 mln vs. $22.96 mln consensus. | ||
| 16:21 | CHRW C.H. Robinson increases quarterly dividend to $0.25 from $0.24 (56.04 +1.35) | |
| 16:21 | RMD ResMed beats by $0.05, beats on revs (50.05 +0.70) | |
| Reports Q1 (Sep) earnings of $0.55 per share, $0.05 better than the First Call consensus of $0.50; revenues rose 13.4% year/year to $247 mln vs the $239.5 mln consensus. | ||
| 16:21 | EZPW EZCORP beats by $0.01, beats on revs; guides Q1 EPS above consensus; guides FY10 EPS above consensus (13.78 +0.70) | |
| Reports Q4 (Sep) earnings of $0.42 per share, $0.01 better than the First Call consensus of $0.41; revenues rose 33.5% year/year to $164.8 mln vs the $160.5 mln consensus. Co issues upside guidance for Q1, sees EPS of $0.41-0.43 vs. $0.40 consensus. Co issues upside guidance for FY10, sees EPS of $1.65-1.69 vs. $1.64 consensus. | ||
| 16:21 | ARP American Reprographics beats by $0.05, beats on revs; reaffirms FY09 EPS guidance (5.70 +0.14) | |
| Reports Q3 (Sep) earnings of $0.06 per share, excluding non-recurring items, $0.05 better than the First Call consensus of $0.01; revenues fell 31.6% year/year to $119.4 mln vs the $116 mln consensus, with gross margins at 36.5%. Co reaffirms guidance for FY09, sees EPS of $0.27-0.33 vs. $0.28 consensus. | ||
| 16:20 | OMPI Obagi Medical reports EPS in-line, misses on revs; guides Q4 EPS in-line, revs in-line (10.59 +0.18) | |
| Reports Q3 (Sep) earnings of $0.14 per share, in-line with the First Call consensus of $0.14; revenues fell 4.2% year/year to $24.9 mln vs the $25.5 mln consensus. Co issues in-line guidance for Q4, sees EPS of $0.16-0.18 vs. $0.16 consensus; sees Q4 revs of $25-27 mln vs. $25.81 mln consensus. | ||
| 16:20 | SD SandRidge Energy reports EPS in-line (10.62 +0.14) | |
| Reports Q3 (Sep) earnings of $0.16 per share, in-line with the First Call consensus of $0.16. Natural gas and crude oil production for the third quarter and first nine months of 2009 was 25.2 Bcfe and 80.6 Bcfe, respectively, compared to 25.3 Bcfe and 73.6 Bcfe, respectively, for the comparable periods of 2008. Lower average commodity prices received during the 2009 periods resulted in natural gas and crude oil revenues of $104.3 million for the third quarter of 2009 compared to $259.1 million for the same period in 2008. Revenues for the first nine months of 2009 declined to $328.6 million from $756.8 million for the first nine months of 2008. | ||
| 16:19 | VRSN VeriSign beats by $0.01, reports revs in-line (24.00 +0.82) | |
| Reports Q3 (Sep) earnings of $0.33 per share, excluding non-recurring items, $0.01 better than the First Call consensus of $0.32; revenues rose 4.9% year/year to $258 mln vs the $258.8 mln consensus. "We had a good quarter and we're pleased with the strength of our core businesses both in terms of growth and operating leverage... As we enter the last quarter of 2009, and with our divestitures essentially behind us, we are focused on growing VeriSign's core businesses." | ||
| 16:19 | HSTX Harris Stratex beats by $0.03, misses on revs; guides Q2 revs below consensus (6.60 +0.21) | |
| Reports Q1 (Sep) loss of $0.01 per share, excluding non-recurring items, $0.03 better than the First Call consensus of ($0.04); revenues fell 38.7% year/year to $120 mln vs the $130.1 mln consensus. Co issues downside guidance for Q2, sees Q2 revs of $120-130 mln vs. $136.90 mln consensus. | ||
| 16:19 | SBUX Starbucks pushes higher in initial reaction to earnings/guidance (19.70 +0.49) -Update- -Technical- | |
| Stock through 20-level, testing underside of mid-October consolidation in 20.40 area. Has considerable resistance at 21.00. Trading at 20.35 after hours. | ||
| 16:18 | ATML Atmel misses by $0.02, beats on revs; guides Q4 revs above consensus (3.91 +0.12) | |
| Reports Q3 (Sep) loss of $0.04 per share, $0.02 worse than the First Call consensus of ($0.02); revenues rose 11.7% year/year to $317.7 mln vs the $303.6 mln consensus. ATML sees Q4 revs up 3-7% QoQ vs the 4.4% consensus. Co issues upside guidance for Q4, sees Q4 revs of $327.2-340 mln vs. $317.01 mln consensus. | ||
| 16:18 | GXDX Genoptix beats by $0.19, beats on revs; raises FY09 EPS guidance, sees revs in-line (34.73 +0.22) | |
| Reports Q3 (Sep) earnings of $0.53 per share, $0.19 better than the First Call consensus of $0.34; revenues rose 58.3% year/year to $50.8 mln vs the $46.7 mln consensus. Co issues guidance for FY09, raises FY09 EPS guidance to $1.60 vs. $1.45 consensus, up from previous guidance of $1.40-1.45; sees FY09 revs of approx. $180 mln vs. $178.81 mln consensus. Gross profit for the third quarter of 2009 was $32.4 million, or 64% of revenues, up from $19.8 million, or 62% of revenues, for the third quarter of 2008. "We made great progress on our hiring initiatives, ending the third quarter with 34 hematopathologists on staff with our Cartesian Medical Group, and 67 sales representatives in the field. The outstanding productivity of these groups has allowed us to revise our hiring plan through the close of 2009, which we now expect to end with the 34 physicians currently on staff, adding more at the start of 2010. Our sales team is expected to expand to approximately 85 field representatives by the end of the year, with additional sales staff to come as the new year begins." | ||
| 16:18 | HAIN Hain Celestial beats by $0.02, misses on revs; reaffirms FY10 EPS guidance, revs guidance (18.84 +1.12) | |
| Reports Q1 (Sep) earnings of $0.25 per share, excluding charges of $1.8 mln, or $0.03 per share, for the planned and previously disclosed consolidation of its two United Kingdom-based fresh food-to-go production facilities, and a $1.0 mln, or $0.02 per share, net loss representing the co's minority interest in the quarterly results of Hain Pure Protein, $0.02 better than the First Call consensus of $0.23; revenues fell 7.2% year/year to $230.5 mln vs the $249.4 mln consensus. Co reaffirms guidance for FY10, sees EPS of $1.19-1.28 vs. $1.23 consensus; sees FY10 revs of $1.0-1.02 bln vs. $1.01 bln consensus. | ||
| 16:18 | APEI American Public Education beats by $0.02, beats on revs; guides Q4 EPS above consensus, revs below consensus; guides FY09 EPS in-line, revs below consensus (32.55 +0.63) | |
| Reports Q3 (Sep) earnings of $0.29 per share, ex-item, $0.02 better than the First Call consensus of $0.27; revenues rose 33.2% year/year to $36.5 mln vs the $36.1 mln consensus. Co issues mixed guidance for Q4, sees EPS of $0.42 vs. $0.41 consensus; sees Q4 revs of $42.7 mln vs. $44.01 mln consensus. Co issues mixed guidance for FY09, sees EPS of $1.24 vs. $1.24 consensus; sees FY09 revs of $148 mln vs. $148.98 mln consensus. Net course registrations from new students in the third quarter of 2009 increased to approximately 14,700, an increase of approximately 41% over the same period of 2008. Net course registrations increased to approximately 55,300 in the third quarter of 2009, a year-over-year increase of 42%. | ||
| 16:18 | NCMI National Cinemedia misses by $0.02, misses on revs; guides FY09 revs below consensus (15.16 -0.15) | |
| Reports Q3 (Sep) earnings of $0.16 per share, $0.02 worse than the First Call consensus of $0.18; revenues fell 11.1% year/year to $95.7 mln vs the $96.9 mln consensus. Co issues downside guidance for FY09, sees FY09 revs of $363-368 mln vs. $369.37 mln consensus. | ||
| 16:17 | CXO Concho Resources beats by $0.02, reports revs in-line (41.37 +1.14) | |
| Reports Q3 (Sep) earnings of $0.37 per share, excluding non-recurring items, $0.02 better than the First Call consensus of $0.35; revenues fell 10.0% year/year to $153.5 mln vs the $154 mln consensus. | ||
| 16:17 | RST Rosetta Stone beats by $0.05, beats on revs; guides Q4 EPS in-line, revs in-line (20.51 +0.57) | |
| Reports Q3 (Sep) earnings of $0.29 per share, $0.05 better than the First Call consensus of $0.24; revenues rose 12.4% year/year to $67.2 mln vs the $65.6 mln consensus. Co issues in-line guidance for Q4, sees EPS of $0.39-0.44 vs. $0.41 consensus; sees Q4 revs of $72-76 mln vs. $74.54 mln consensus. | ||
| 16:17 | PRO Pros Holdings reports EPS in-line, beats on revs; guides Q4 EPS below consensus, revs above consensus (9.18 +0.42) | |
| Reports Q3 (Sep) earnings of $0.07 per share, in-line with the First Call consensus of $0.07; revenues fell 14.5% year/year to $16.5 mln vs the $16.3 mln consensus. Co issues mixed guidance for Q4, sees EPS of 0.06-0.07 vs. $0.08 consensus; sees Q4 revs of $16.6-17.0 vs. $16.49 mln consensus. | ||
| 16:16 | SBUX Starbucks raises FY10 EPS to be +15-20% y/y compared to previous guidance of +13-18% -Update- | |
| 16:16 | IPAS iPass announces form of $20 mln capital distribution to stockholders; announces special cash dividen of $0.16 per share (1.35 +0.04) | |
| Co announces that its board of directors has adopted a plan of distribution for a second $20 mln distribution of capital to stockholders. iPass has already executed on its commitment to distribute $20 mln of capital to stockholders through a special $0.32 per share cash dividend that was paid in September 2009; this second $20 mln distribution will be comprised of two parts: a special cash dividend of $10 mln or $0.16 per share, and the launching of a $10 mln stock repurchase program. The special cash dividend of $10 million or approximately $0.16 per share will be paid in the fourth quarter of 2009; the record date for the special cash dividend is December 4, 2009 and the payment date will be December 18, 2009. The $10 mln stock repurchase program goes into effect on November 15, 2009 and extends through March 31, 2011. Under the terms of the program, iPass may purchase up to $10 mln of its common stock through open market, block and/or negotiated trades. Additionally, in the event that the full $10 mln has not been used to repurchase the company's stock by March 31, 2011, the company has committed to dividend to stockholders any remaining balance by April 15, 2011. In connection with this plan, iPass also announced that the company and Foxhill Capital amended the terms of their agreement to provide iPass with the ability to structure this $20 mln distribution of capital through a combined cash dividend and stock buyback program. | ||
| 16:16 | NP Neenah Paper renews credit facility through 2013 (11.45 +0.64) | |
| Co announces that it has successfully renewed its North American senior secured credit facility. The existing facility was set to expire in November 2010. As of June 30, the Company had $84 mln drawn against this facility and remaining available capacity of $52 mln. The amended and restated facility, with an initial size of $140 mln, expires in November 2013. The lending group consists of JPMorgan Chase Bank, Bank of America, UBS and Goldman Sachs. | ||
| 16:16 | ZGEN Zymogenetics beats by $0.03, misses on revs (5.13 +0.22) | |
| Reports Q3 (Sep) loss of $0.17 per share, $0.03 better than the First Call consensus of ($0.20); revenues rose 131.1% year/year to $27.5 mln vs the $31.5 mln consensus. | ||
| 16:15 | GPI Group 1 Auto acquires BMW dealership in Mobile, Alabama (25.65 +0.27) | |
| Co announces that it acquired the only BMW franchise in Mobile, Ala. The dealership will operate as BMW of Mobile, under Group 1's Eastern Region, and is expected to generate an estimated $37.7 mln in annual revenues. Including this acquisition, Group 1 now owns and operates 11 BMW dealerships in the United States and three in the United Kingdom. | ||
| 16:14 | ALKS Alkermes reports EPS in-line, beats on revs; lowers FY10 guidance (8.09 +0.26) | |
| Reports Q2 (Sep) loss of $0.09 per share, in-line with the First Call consensus of ($0.09); revenues rose 1.9% year/year to $48.2 mln vs the $45.9 mln consensus. Co lowers FY10 guidance, sees FY10 revs of $168-183 vs. $185.61 mln consensus. The company is adjusting its expectation for net loss to a range of $45 to $55 million, revised from an expectation of $30 to $40 million. | ||
| 16:14 | CBS CBS Corp beats by $0.17, beats on revs (12.79 +0.89) | |
| Reports Q3 (Sep) earnings of $0.39 per share, excluding non-recurring items, $0.17 better than the First Call consensus of $0.22; revenues fell 0.8% year/year to $3.35 bln vs the $3.19 bln consensus. The Company continues to expect full year 2009 OIBDA to be in the range of $1.725 billion to $1.925 billion. | ||
| 16:14 | COHR Coherent beats by $0.05, beats on revs; guides FY10 revs above consensus (26.17 +1.33) | |
| Reports Q4 (Sep) loss of $0.04 per share, $0.05 better than the First Call consensus of ($0.09); revenues fell 24.2% year/year to $107.6 mln vs the $96.5 mln consensus. Co issues upside guidance for FY10, sees FY10 revs of $475-500 mln vs. $456.47 mln consensus. "The fourth quarter lived up to our expectations as a turning point for bookings with double-digit, sequential growth in all four end markets. Microelectronics was particularly robust as service orders responded to higher fab utilization rates, capacity expanded for OLEDs and mobile touch screen displays and additional design wins were secured. The scientific research market was also very active with record total bookings and record unit volumes for our Chameleon(TM) and amplifier product lines due to the strength of the products as well as benefits from U.S. stimulus funds. Finally, a number of our instrumentation and medical OEM customers reverted to annual buying patterns, which signals confidence in their end markets." | ||
| 16:14 | BEBE bebe stores misses by $0.02, reports revs in-line; guides Q2 EPS in-line (6.53 +0.17) | |
| Reports Q1 (Sep) loss of $0.05 per share, $0.02 worse than the First Call consensus of ($0.03); revenues fell 23.0% year/year to $125.7 mln vs the $125.7 mln consensus. Co issues in-line guidance for Q2, sees EPS of $0.00-0.05 vs. $0.05 consensus. Gross margin as a percentage of net sales decreased to 36.7% in the first quarter of fiscal 2010, compared to 44.9% in the first quarter of fiscal 2009. For the second quarter of fiscal 2010, the Company is currently planning finished goods inventory to be down on a per square foot basis compared to the second quarter of fiscal 2009 in the mid to high teens. | ||
| 16:13 | NILE Blue Nile beats by $0.01, beats on revs; guides Q4 EPS above consensus, revs above consensus (58.72 +2.13) | |
| Reports Q3 (Sep) earnings of $0.17 per share, $0.01 better than the First Call consensus of $0.16; revenues rose 2.3% year/year to $66.9 mln vs the $65.6 mln consensus. Co issues upside guidance for Q4, sees EPS of $0.35-0.39 vs. $0.33 consensus; sees Q4 revs of $100-109 mln vs. $95.88 mln consensus. Co says "Our third quarter results were excellent and reflect continued positive momentum in the business. We returned to top line growth and delivered strong profitability, The Blue Nile brand is resonating with consumers in the current environment, and we are gaining market share. As we look toward the important holiday season, we are well positioned with a broad selection of diamond engagement rings and fine jewelry and a newly redesigned website to showcase these products." | ||
| 16:13 | POR Portland Gen Elec Files Energy Resource Plan with Public Utility Commission (18.97 +0.32) | |
| Co announces that it filed a comprehensive resource plan with the Oregon Public Utility Commission, outlining proposed strategies to meet its customers' electricity needs over the next 20 years. The plan is the result of many months of analysis and research, including a half-dozen day-long public workshops held over the course of the planning process to solicit input from customer advocates, regulators, energy experts, and other key stakeholders. PGE projects that demand for electricity in the area it serves will increase by an average of 2.3 percent per year or 20 percent by 2020. PGE's plan includes a four-year strategy for acquisition of new resources and a 20-year strategy that outlines long term expectations for the utility's resource needs and portfolio performance. | ||
| 16:13 | ROVI Rovi misses by $0.04, misses on revs; raising lower end of FY09 EPS guidance in-line, revs below consensus (28.17 +0.37) | |
| Reports Q3 (Sep) earnings of $0.33 per share, excluding non-recurring items, $0.04 worse than the First Call consensus of $0.37; revenues rose 6.3% year/year to $115.3 mln vs the $120.8 mln consensus. Co says agreements already closed early in Q4 improve our 2009 visibility and we are raising the low end of the 2009 revenue and earnings estimates and narrowing the range for the balance of 2009. Co sees EPS guidance for FY09 of $1.45-1.50 vs. $1.48 consensus, from prior guidance of $1.40-1.50; sees FY09 revs of $475-480 mln vs. $480.66 mln consensus, from $465-485 mln. | ||
| 16:13 | MRT Mortons Restaurant Group misses by $0.09, misses on revs; guides Q4 EPS in-line, revs in-line (3.45 -0.08) | |
| Reports Q3 (Sep) loss of $0.16 per share, $0.09 worse than the First Call consensus of ($0.07); revenues fell 12.2% year/year to $64.1 mln vs the $69.7 mln consensus. Morton's revenues and results have been pressured by the continuing global recession, which has impacted guest traffic throughout the industry. Negative comparable restaurant revenues adversely impacted earnings due to the deleveraging effect on the fixed cost base. Co issues in-line guidance for Q4, sees EPS of $0.22-$0.25 vs. $0.24 consensus; sees Q4 revs of $82-$84 mln vs. $83.81 mln consensus. Co also sees a decreases in comparable restaurant revenues for Morton's steakhouses of approximately 10%-12% YoY. | ||
| 16:12 | HANS Hansen Natural misses by $0.03, reports revs in-line (36.94 ) | |
| Reports Q3 (Sep) earnings of $0.60 per share, $0.03 worse than the First Call consensus of $0.63; revenues rose 8.0% year/year to $307.9 mln vs the $309.2 mln consensus. Gross profit, as a percentage of net sales, for the 2009 third quarter was 53.6%, compared with 52.4% for the comparable 2008 quarter. Distribution costs as a percentage of net sales were 4.3 percent for the 2009 third quarter, compared with 5.5 percent in the same quarter last year. Co states, "The transition to certain Coca-Cola bottlers and new Anheuser-Busch distributors at the end of last year continues to be beneficial as the company's national market share in both the convenience and gas and grocery channels is now higher than it was prior to the transition. In fact, Monster Energy's market share in the important convenience and gas channel increased to 30% for the first time during the five weeks ended September 26, 2009." | ||
| 16:12 | GXDX Genoptix beats by $0.19, beats on revs; guides FY09 EPS above consensus, revs above consensus; guides FY10 revs above consensus (34.73 +0.22) | |
| Reports Q3 (Sep) earnings of $0.53 per share, $0.19 better than the First Call consensus of $0.34; revenues rose 58.3% year/year to $50.8 mln vs the $46.7 mln consensus. Co issues upside guidance for FY09, sees EPS of ~$1.60 vs. $1.45 consensus; sees FY09 revs of ~$180 mln vs. $178.81 mln consensus. Co issues upside guidance for FY10, sees FY10 revs of ~$235 mln vs. $232.67 mln consensus. | ||
| 16:12 | SAPE Sapient Govt Services awarded contract to expand strategic forensic evidence management program (8.60 +0.32) -Update- | |
| Co announces an award by the U.S. Department of Justice, Federal Bureau of Investigation to support the implementation of INNOVARi, a strategic forensic management program for the FBI's Laboratory Division and Operational Technology Division. The INNOVARi program has created an automated information management and evidence tracking system to ensure all forensic evidence is properly handled and the information produced in connection with forensic examinations is managed for the FBI, as well as its Federal, state, local, and international law enforcement customers. The contract, valued at up to $15 mln over a five-year period, will allow Sapient and the FBI to continue supporting INNOVARi in the LD and extend it into the OTD to fully realize the Bureau's vision for the program. | ||
| 16:11 | IGT Intl Game Tech beats by $0.02, beats on revs (18.56 -0.04) | |
| Reports Q4 (Sep) earnings of $0.19 per share, $0.02 better than the First Call consensus of $0.17; revenues fell 18.6% year/year to $514.6 mln vs the $497.9 mln consensus. Product sales revenues and gross profit in the fourth quarter declined 23% and 26%, respectively, while units shipped worldwide decreased 30% over the prior year quarter. North America revenues decreased 31% for the quarter and 16% for the fiscal year, largely driven by fewer new openings and replacement sales. International revenues declined 11% for the quarter and 31% for the fiscal year as international markets continue to feel the effects of the economic slowdown, most notably in Continental Europe, Japan and South America, and unfavorable changes in currency exchange rates. Consolidated gross margin on product sales for the quarter was 51% compared to 54% in the prior year quarter, and 50% for the full year compared to 54% last year. Both periods were unfavorably impacted by lower volumes spread across fixed manufacturing costs, as well as higher costs related to systems upgrades and fewer systems sales, which carry higher margins. "While we remain cautious on the timing and extent of the replacement cycle, we have been encouraged by modest upticks in spending by many of our casino operator customers over the past two quarters." | ||
| 16:11 | INAP InterNAP beats by $0.05, reports revs in-line (3.18 +0.14) | |
| Reports Q3 (Sep) loss of $0.02 per share, excluding non-recurring items, $0.05 better than the First Call consensus of ($0.07); revenues fell 1.5% year/year to $64.4 mln vs the $64.6 mln consensus. | ||
| 16:11 | EGOV NIC Inc beats by $0.01, beats on revs (8.65 +0.26) | |
| Reports Q3 (Sep) earnings of $0.06 per share, $0.01 better than the First Call consensus of $0.05; revenues rose 49.8% year/year to $37.3 mln vs the $34.9 mln consensus. For fiscal year 2010, NIC currently expects total revenues from the new Texas contract, including related Master Work Order projects, to range from $32.0 - $36.0 mln, with gross profit margins in the low-to-mid 20 percent range. | ||
| 16:10 | SWK Stanley Works to record one time charge of $18.0 million in fourth quarter 2009 related to Black & Decker Transaction; no change in operational outlook (49.62 +1.17) | |
| The Company expects to record a one time charge in the fourth quarter of 2009 of $18.0 million, reflecting fees and expenses related to the Black & Decker transaction, the majority of which are non tax-deductible. As a result, the Company is revising its previous full year 2009 earnings per share guidance of $2.84-$2.94 per share to $2.61-$2.71 per share vs $2.58 First Call consensus. Management continues to expect gross margins of 40% and free cash flow to be in excess of $300 million for the full year. The revision in the Company's guidance does not reflect any change in its operational outlook. | ||
| 16:10 | CSV Carriage Services amends and extends credit facility (4.45 +0.37) | |
| Co announces that effective November 4, 2009, it has amended and extended its existing senior secured bank revolving credit facility with its lenders, Bank of America and Wells Fargo. Prior to the transaction, the $20 mln credit facility was scheduled to mature in April 2010. The amended credit facility is in the amount of $40 mln with an accordion provision for an additional $20 mln and matures in November 2012. The primary purpose of the credit facility is to provide acquisition financing. As of this date, the facility is undrawn. | ||
| 16:10 | NABI NABI Biopharma beats by $0.02 (3.40 +0.15) | |
| Reports Q3 (Sep) loss of $0.14 per share, $0.02 better than the First Call consensus of ($0.16). Co has no revs. Net cash used in operating activities from continuing operations was $18.1 million for the first nine months ended September 26, 2009 compared to $16.0 million used in the first nine months of 2008. | ||
| 16:09 | VOLC Volcano reports Q3 EPS of ($0.08) vs ($0.12) First Call consensus; revs $53.9 mln vs $53.37 mln First Call consensus (14.98 +0.40) | |
| Volcano sees FY09 EPS of ($0.38)-($0.43) vs ($0.41) First Call consensus; sees revs $218-223 mln vs $220.62 mln First Call consensus | ||
| 16:09 | JDSU JDS Uniphase beats by $0.02, beats on revs; guides Q2 revs above consensus (6.07 +0.29) | |
| Reports Q1 (Sep) earnings of $0.04 per share, excluding non-recurring items, $0.02 better than the First Call consensus of $0.02; revenues fell 21.0% year/year to $297.8 mln vs the $291.8 mln consensus. Co issues upside guidance for Q2, sees Q2 revs of $320-345 mln vs. $306.14 mln consensus. | ||
| 16:09 | ABVT Abovenet beats by $0.22, beats on revs; guides FY09 revs above consensus (51.00 +2.62) | |
| Reports Q3 (Sep) earnings of $0.96 per share, $0.22 better than the First Call consensus of $0.74; revenues rose 12.5% year/year to $92.4 mln vs the $88.8 mln consensus. Co issues upside guidance for FY09, sees FY09 revs of $355-360 mln vs. $354.76 mln consensus. Adjusted EBITDA Margin for 2009 is expected to be roughly in line with the actual Adjusted EBITDA Margin for the first nine months of 2009 of 44.2%. Cash used for capital expenditures for 2009 is expected to be between $110 million and $120 million. Management reiterated that it expects Adjusted EBITDA to exceed cash used for capital expenditures in 2009. (GROWX) | ||
| 16:09 | ATEC Alphatec enters supply and distribution agreement with ETEX Corporation for novel biologics products (4.93 +0.38) | |
| Alphatec Holdings, the parent company of Alphatec Spine announces that it has entered into a supply and distribution agreement with ETEX Corporation, pursuant to which ETEX will provide Alphatec Spine non-exclusive rights to market and sell ETEX's EquivaBone and CarriGen products in the United States and Europe, excluding Spain. | ||
| 16:08 | JAZZ Jazz Pharma beats by $0.09, beats on revs (6.51 +1.05) | |
| Reports Q3 (Sep) loss of $0.05 per share, $0.09 better than the First Call consensus of ($0.14); revenues rose 74.0% year/year to $30.8 mln vs the $28.7 mln consensus. XYREM? (sodium oxybate) oral solution net sales for the third quarter of 2009 were $25.0 million, compared to $14.2 million for the third quarter of 2008, and represented a 12% sequential increase over net sales of $22.4 million for the second quarter of 2009. Net sales of once-daily LUVOX CR? (fluvoxamine maleate) extended-release capsules were $5.0 million for the third quarter of 2009, compared to $2.0 million for the third quarter 2008, and represented a 20% sequential increase over net sales of $4.1 million for the second quarter of 2009. | ||
| 16:07 | CPKI California Pizza reports EPS in-line, revs in-line; guides Q4 EPS below consensus (13.84 +0.25) | |
| Reports Q3 (Sep) earnings of $0.24 per share, in-line with the First Call consensus of $0.24; revenues fell 5.3% year/year to $164.8 mln vs the $164.8 mln consensus. Co issues downside guidance for Q4, sees EPS of $0.16-0.18 vs. $0.20 consensus. Full service comparable restaurant sales decreased 8.0%; with comparable restaurant sales between negative 5.5% and negative 6.5%. | ||
| 16:07 | SAM Boston Beer Co beats by $0.33, beats on revs; raised FY09 EPS guidance above consensus (37.44 +0.48) | |
| Reports Q3 (Sep) earnings of $0.72 per share, excluding non-recurring items, $0.33 better than the First Call consensus of $0.39; revenues rose 7.5% year/year to $108.7 mln vs the $107.5 mln consensus. Co raises guidance for FY09, sees EPS of $1.75-2.05 vs. $1.72 consensus, up from $1.40-1.70. | ||
| 16:07 | AMSF Amerisafe beats by $0.20, misses on revs (18.62 +0.04) | |
| Reports Q3 (Sep) earnings of $0.74 per share, $0.20 better than the First Call consensus of $0.54; revenues fell 11.9% year/year to $67.2 mln vs the $72.8 mln consensus. | ||
| 16:07 | SAPE Sapient beats by $0.04, beats on revs; guides Q4 revs above consensus (8.60 +0.32) | |
| Reports Q3 (Sep) earnings of $0.11 per share, excluding non-recurring items, $0.04 better than the First Call consensus of $0.07; service revenues fell 6.9% year/year to $165.5 mln vs the $162 mln consensus. Co issues upside guidance for Q4, sees Q4 service revs of $172-175 mln vs. $168.62 mln consensus. | ||
| 16:06 | CROX Crocs reports Q3 (Sep) results, beats on revs; guides Q4 EPS in-line, revs in-line (6.84 +0.53) | |
| Reports Q3 (Sep) earnings of $0.25 per share, may not be comparable to the First Call consensus of ($0.08); revenues rose 1.7% year/year to $177.1 mln vs the $156.4 mln consensus. Third quarter 2009 net income includes the effects of the following: $9.6 million gross margin impact related to sales of product that had been previously impaired -- $1.0 million gain from foreign currency exchange rate fluctuations during the 2009 third quarter, and -- $14.4 million one-time tax benefit related to a change in the Company's corporate tax structure. On a non-GAAP basis, co reports EPS of $0.01. Co issues in-line guidance for Q4, sees EPS of ($0.20)-($0.15) vs. ($0.16) consensus; sees Q4 revs of 110-115 vs. $113.62 mln consensus. "While we are encouraged by our top-line growth and return to profitability in the quarter, the normal seasonality of our business will make it difficult to maintain profitability in the fourth quarter. However, future wholesale bookings for the spring 2010 line are strong in all regions. When coupled with the launch of our new, targeted marketing programs, this provides us with increased confidence that we will return to profitability during 2010. In the meantime, we will continue to invest in the products, systems, processes and customer relationships necessary to deliver the best long-term results." | ||
| 16:06 | NTLS Ntelos Holdings misses by $0.01, misses on revs; guides FY09 revs below consensus (15.45 -0.20) | |
| Reports Q3 (Sep) earnings of $0.34 per share, $0.01 worse than the First Call consensus of $0.35; revenues rose 0.5% year/year to $135.7 mln vs the $139.2 mln consensus. Co issues downside guidance for FY09, sees FY09 revs of $549-553 mln vs. $561.12 mln consensus. Expenditures related to the acquisition of fiber optic assets from Allegheny Energy, Inc. are not included in 2009 Wireline capital expenditure outlook. | ||
| 16:05 | THRX Theravance and Astellas announce the commercial launch of VIBATIV in the United States (14.66 +0.90) | |
| Theravance (THRX) and Astellas Pharma announce the commercial launch of VIBATIV in the United States. On September 11, 2009, the U.S. Food and Drug Administration approved VIBATIV for the treatment of adult patients with complicated skin and skin structure infections caused by susceptible Gram-positive bacteria, including Staphylococcus aureus, both methicillin-resistant and methicillin-susceptible strains. VIBATIV is a bactericidal, once-daily injectable lipoglycopeptide antibiotic discovered by Theravance. | ||
| 16:05 | BAGL Einstein Noah beats by $0.01, misses on revs (13.31 +0.33) | |
| Reports Q3 (Sep) earnings of $0.28 per share, $0.01 better than the First Call consensus of $0.27; revenues fell 0.8% year/year to $100 mln vs the $101.4 mln consensus. | ||
| 16:05 | MIL Millipore beats by $0.02, beats on revs (68.76 +0.66) | |
| Reports Q3 (Sep) earnings of $0.95 per share, $0.02 better than the First Call consensus of $0.93; revenues rose 4.3% year/year to $412 mln vs the $405.8 mln consensus. Millipore. "Our top-line growth is being driven by our Bioprocess Division, which is benefitting from increased spending from large biotechnology customers, strong demand for products used to manufacture the H1N1 flu vaccine, and expanded sales in Asia. We continue to drive above-market growth in our Bioscience Division due to the resiliency of our consumable product portfolio and strength at academic customers. This growth is being partially offset by weakness at large pharmaceutical accounts, particularly for drug discovery services and laboratory instrumentation." | ||
| 16:05 | ITMN InterMune beats by $0.02, beats on revs (13.72 +0.21) | |
| Reports Q3 (Sep) loss of $0.19 per share, $0.02 better than the First Call consensus of ($0.21); revenues rose 17.2% year/year to $27.3 mln vs the $26.7 mln consensus. | ||
| 16:05 | CROX Crocs gives it ups initial post earnings push as it sinks down into its key 2-mth range lows near 5.75-6.00, currently trading at 5.93 x 6.00 -Update- -Technical- | |
| Initial spike high near 7.40. | ||
| 16:04 | RRGB Red Robin Gourmet reports EPS in-line, misses on revs (17.70 +0.69) | |
| Reports Q3 (Sep) earnings of $0.37 per share, in-line with the First Call consensus of $0.37; revenues fell 10.4% year/year to $187 mln vs the $197.5 mln consensus. Comparable sales in 3Q09 for franchise restaurants in the U.S. decreased 14.4% and for franchise restaurants in Canada decreased 0.2% from the 3Q08. The company continues to expect that guest counts will be negative for the FY09. In addition to the general macroeconomic pressures, the extent of the traffic declines have also been impacted by prior-year marketing activities, which create more difficult comparisons during certain periods. As a result of the impact of deleveraging on restaurant margins from decreased restaurant sales and the y/y cost pressures from select food and minimum wage increases, as well as some recent advertising expenses, the company expects restaurant-level operating margins could decline by 150 to 160 basis points for the fiscal year 2009. For every 10 basis point change in restaurant level operating profit during fiscal year 2009, diluted earnings per share are estimated to be impacted by approximately $0.04. | ||
| 16:03 | BMRN Biomarin Pharm: United States Patent Office issues patent covering the approved administration of Kuvan with food (16.30 +0.58) | |
| Co announces that the United States Patent and Trademark Office has issued a patent covering the approved administration of Kuvan with food for the treatment of phenylketonuria. The patent expires in 2024. | ||
| 16:03 | CAP CAI Intl beats by $0.03, misses on revs (7.34 +0.43) | |
| Reports Q3 (Sep) earnings of $0.18 per share, $0.03 better than the First Call consensus of $0.15; revenues fell 29.0% year/year to $15.7 mln vs the $15.9 mln consensus. | ||
| 16:03 | ASEI American Science & Engineering beats by $0.31, beats on revs (70.35 +1.43) | |
| Reports Q2 (Sep) earnings of $1.18 per share, $0.31 better than the First Call consensus of $0.87; revenues rose 8.8% year/year to $61.2 mln vs the $60.1 mln consensus. Bookings in the quarter were $90,312,000 resulting in a backlog of $187,427,000 as of September 30, 2009. | ||
| 16:03 | AIRM Air Methods beats by $0.24, beats on revs (32.69 +2.67) | |
| Reports Q3 (Sep) earnings of $1.01 per share, $0.24 better than the First Call consensus of $0.77; revenues rose 2.8% year/year to $137.6 mln vs the $135.2 mln consensus. | ||
| 16:02 | ZINC Horsehead Holding misses by $0.03, misses on revs (10.11 ) | |
| Reports Q3 (Sep) loss of $0.10 per share, $0.03 worse than the First Call consensus of ($0.07); revenues fell 44.8% year/year to $60.3 mln vs the $64.1 mln consensus. | ||
| 16:02 | BMTI Biomimetic Therapeutics reports Q3 EPS of ($0.36) vs ($0.42) First Call consensus; revs $0.3745 mln vs $0.53 mln First Call consensus (11.62 -0.02) | |
| Based on current operating plans, forecasted timing and costs of clinical trials and other product development programs, the Company anticipates its 2009 year-end balance of cash, cash equivalents and investments to range from $88.0 to $95.0 million, and anticipates that its net cash use will be between $2.0 and $9.0 million. This includes the $4.0 million remaining time-based payment expected later in 2009 related to the sale of its orofacial therapeutic business to Luitpold Pharmaceuticals, Inc. Loss before income taxes for the year ending December 31, 2009 is forecasted to be in the range of $31.0 to $38.0 million. | ||
Feeds!